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Overview of thesis 
This thesis follows the portfolio format and the following information provides a 
brief summary of the main chapters of the thesis:  
Chapter 1 is a systematic review and meta-analysis of the research literature 
exploring the risk factors and correlates of impaired treatment decision making 
capacity in people who have experienced psychosis. Chapter 2 presents a research 
journal article which explores the role of cognitive biases in the treatment decision 
making capacity of people who have experienced psychosis. The thesis portfolio 
concludes with a complete reference list for the whole thesis and an appendix 
section, which allows the reader to access extra information related to the research 
process. 
The systematic review and empirical journal article were written for submission to 
the Journal of Clinical Psychology. The author guidelines for this journal are 











Purpose: A systematic review and meta-analysis was conducted to identify what 
factors have been investigated as correlates of the 4 key domains of treatment 
decision making capacity (TDMC) in people who have experienced psychosis 
(understanding, reasoning, appreciation, communication) and to provide estimates of 
the magnitude of these correlations, taking into account study quality. A novel 
empirical study was conducted to test the hypothesis that variance in psychosis-
specific cognitive biases (including the well-established ‘jumping to conclusions’ 
bias) would account for unique variance in TDMC domains in those with psychosis, 
after taking into account the known contribution of symptoms and insight. A 
secondary aim of the empirical study was to examine for the first time the 
relationship between TDMC and personal recovery in this group, and post hoc 
analyses of the relationship between cognitive biases, emotional distress and TDMC 
were also conducted.   
Methods: Electronic databases were systematically searched for literature on the 
schizophrenia and psychosis and treatment decision making capacity. Pooled 
estimates of correlation were estimated for factors with data from three or more 
studies, and both study and outcome quality were systematically assessed. A cross-
sectional observational study was conducted, and individuals with psychosis 
completed measures of TDMC, cognitive biases, psychotic symptoms and recovery. 
Multiple regression was used to examine the primary and secondary hypotheses, and 
mediation analyses were used to conduct the post hoc analyses. Additional data from 
a parallel study was incorporated to increase power.  
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Results: Twenty-four studies met inclusion criteria for the systematic review and 
meta-analysis. Low to moderate quality evidence suggested that the ability of people 
with psychosis to understand treatment-relevant information was strongly associated 
with overall psychotic symptom severity, verbal cognitive functioning and years of 
education, but not depression (moderate quality evidence). Low quality evidence 
suggested reasoning was strongly associated with verbal cognitive functioning and 
moderately associated with symptoms. Appreciation was associated with symptoms, 
but it and communication were generally poorly studied. Findings from the empirical 
study suggest that cognitive biases, and the Jumping to Conclusions bias in 
particular, predicts a moderate amount of the variance in the understanding and 
reasoning TDMC domains, but did not add predictive power to a model containing 
symptoms, insight, and cognition. The appreciation domain was strongly predicted 
by cognitive biases, insight, and cognition. TDMC was not found to be correlated 
with personal recovery and post hoc analyses did not find that emotional distress 
mediated any relationship between cognitive biases and TDMC.  
Conclusions:  The meta-analysis confirms there is a robust association between 
symptoms and TDMC in psychosis, as currently conceived. The empirical study 
suggests cognitive biases may be related to TDMC, even after taking into account the 
contribution of symptoms. Larger studies, perhaps employing experimental 
procedures, are required to clarify the exact nature of this relationship. The lack of 
any relationship between TDMC and service-user defined recovery from psychosis is 
notable, and lends support to those calling for a conceptualisation of TDMC that 




Chapter 1: Systematic review and meta-analysis 
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Objectives: To improve our theoretical understanding of treatment decision-
making capacity (TDMC) in psychosis, we did a systematic review and meta-
analysis to identify risk factors associated with impairment, taking into account 
the quality of the literature.  
Method: We searched EMBASE, Medline and PsycInfo for relevant studies. 
For each potential correlate that had been examined, we computed standardised 
effect sizes and 95% confidence intervals, and presented these within an 
assessment of study quality. Random-effects meta-analyses were conducted 
when there were at least 3 relevant studies, with the quality of the estimates 
assessed using GRADE.  
Results: Twenty-four relevant studies were identified, providing data from 
1,823 participants with psychosis. Low to moderate quality evidence suggested 
that the ability of people with psychosis to understand treatment-relevant 
information was strongly associated with overall psychotic symptom severity, 
verbal cognitive functioning and years of education, but not depression 
(moderate quality evidence). Low quality evidence suggested TDMC-related 
reasoning ability was strongly associated with verbal cognitive functioning and 
moderately associated with symptoms. The appreciation domain had a smaller 
association with symptoms, but both it and communication domain were 
generally poorly studied. Emerging evidence identified insight, shorter duration 
of illness, metacognitive awareness, and use of specific interventions such as 
altering the presentation of information as factors linked to improved TDMC.  
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Conclusions: Symptoms, verbal cognitive functioning and duration of 
education are robustly associated with components of treatment decision-
making capacity in psychosis. However, we lack data on the role of cognitive 
biases, appraisals or wider social factors such as stigma, and only two 
randomised controlled trials have tested strategies to support decision-making 
capacity.    






Capacity is a term that has its origins in legislation, but has become increasingly 
relevant to clinical practice. In the Adults with Incapacity (Scotland) Act (2000), a 
judgment of incapacity is justified when the following conditions are met: that the 
person is incapable of (a) acting; or (b) making decisions; or (c) communicating 
decisions; or (d) understanding decisions; or (e) retaining the memory of decisions. 
Research in the area of decision-making capacity has centred on a model of capacity 
defined by Appelbaum and Grisso (1995) which defined capacity in terms of four 
abilities; ability to communicate a choice, ability to understand relevant information, 
ability to appreciate the situation and ability to manipulate information rationally 
(i.e., the ability to reason). This model fits with the legal definition of capacity to 
make decisions in the United Kingdom (Mental Capacity Act, 2005; Adults with 
Incapacity (Scotland) Act, 2000), and focuses on the person’s ability to understand 
and apply information relating to the specific decision to be made.  
Capacity has become an increasingly important concept in mental health care. Under 
current UK legislation a judgement of impaired treatment decision-making capacity 
(TDMC) by a healthcare professional can represent the point whereby a person 
experiences a formal loss of autonomy and accountability in relation to healthcare 
decisions. The focus on patient autonomy in mental health law in the UK can be 
traced back to a Department of Health review of Mental Health Law, which stated 
that:  
“The desire to promote non-discrimination on the grounds of mental health has led 
inevitably to an emphasis on patient autonomy. In the context of physical health a 
patient with capacity is free to choose whether or not to accept treatment: his or her 
autonomy is respected” (Department of Health, 1999, p. 18).  
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Autonomy is protected under human rights legislation, for example Article 12 of the 
United Nations Convention on the Rights of Persons with Disabilities recognises the 
right to be recognised as a person before the law, and the subsequent right to have 
one’s decisions legally recognised. Research on recovery in mental health has also 
found that autonomy and empowerment are key components of people’s perceived 
wellness and recovery (Pitt et al., 2007; Law & Morrison, 2014; SAMHSA, 2008). 
The Adults with Incapacity (Scotland) Act (2000) requires clinicians to empower 
patients to make decisions and to make an assumption of capacity until proven 
otherwise. However, if patients who lack capacity are allowed to make decisions, 
these may not reflect their true wishes and the consequence may be a poor outcome 
and inadequate protection of the patient (Lepping, 2011). Capacity has been called 
the “gatekeeper for autonomy” (Donnelly, 2010). 
Although the concept of decisional capacity for consent emerged from case law and 
legislation, and is closely tied to the legal concept of competency, clinicians (often 
psychiatrists) are usually charged with assessing this (Candia & Barba, 2011). 
Consultations on decision-making capacity constitute 1 in 6 referrals to psychiatry 
(Seyfried, Ryan, & Kim, 2013), and a recent systematic review by Lepping, Stanley, 
& Turner (2015) found that the average percentage of patients with impaired TDMC 
on psychiatric wards is 45%.  A review by Jeste et al. (2006) found between 10% and 
52% of people diagnosed with schizophrenia and psychosis were judged to have 
impaired TDMC. However, despite the frequency with which psychiatrists are asked 
to make such judgements, almost 50% of them judged the evidence base in this area 
to be weak (Seyfried, Ryan, & Kim, 2013).  
The field of decision-making capacity research has grown in the last number of 
years. This has been spurred on by changes in legislation, but also by a change in the 
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culture in which healthcare decisions are made. Users of mental health services are 
showing a greater desire to be included in decisions about their treatment (Hamann et 
al., 2005: Hill & Laughrane, 2006). There has been an increasing emphasis on 
ensuring that not only are patients giving their informed consent to treatment, but 
also that they are actively involved in the decision making process (NICE, 2011). 
The most common model for involving patients in decision-making is ‘shared 
decision-making’, which involves including the service user as partners in medical 
and mental health care decision making (Hamann et al., 2003). There is evidence that 
only a minority of people with psychosis experience this, with only 41% of people 
surveyed as part of the Second National Audit of Schizophrenia reporting that they 
felt adequately involved in decisions about medication (Royal College of 
Psychiatrists, 2014). Since impaired capacity is a major barrier to psychiatrists 
implementing shared decision-making with people with psychosis (Hamann et al., 
2009), improving our understanding of factors that cause or maintain this impairment 
may help to ensure that greater numbers of patients are involved in a shared decision 
making process.  
British Medical Association (2013) guidance on capacity states that it is the duty of 
the assessing clinician to enhance capacity where it is possible to do so. In the 
context of psychiatric and mental health conditions, this is often achieved through 
treatment of the condition itself; however there has been little research on the 
effectiveness of current treatment as usual in enhancing decision making capacity. 
Although some studies have examined whether specific psychological and 
educational interventions can enhance TDMC (Carpenter et al., 2000; Naughton et 
al., 2012), these have yet to be systematically reviewed.  
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Candia & Barba (2011) summarised the current position of research in relation to 
mental capacity and consent to treatment in psychiatric patients, and concluded that 
the field is still growing and the literature is often difficult to interpret. Systematic 
reviews have variously examined the prevalence of incapacity in psychiatric patients 
(Okai et al. 2007), the reliability and validity of instruments used to assess treatment 
and research capacity (Dunn et al., 2006; Sturman et al., 2005), the degree of 
impairment in decisional capacity in schizophrenia (Jeste, Depp, & Palmer, 2006), 
the relationship between competence and poor insight (Ruissen et al., 2012) and the 
associations of specific neuropsychological deficits with capacity to consent to 
treatment or research (Palmer & Salva, 2007). Although one older review examined 
the correlates of TDMC in psychiatric populations generally (Okai et al., 2007), no 
reviews have yet looked at the factors associated with TDMC in people with 
psychosis specifically.   
Psychosis is a transdiagnostic term that is used to describe experiences such as 
hearing voices, holding strong beliefs that others around you do not, difficulties with 
thinking and concentrating, and emotional changes (BPS, 2014).  Research occurs 
under a paradigm or set of assumptions that is often unconscious (Bentall, 2003). In 
research on schizophrenia and psychosis, this set of assumptions often includes the 
assumption that the diagnosis of psychotic disorders is reliable and valid. However, 
there have been criticisms of the diagnosis of psychotic disorders for many decades 
now (Bentall, Jackson, & Pilgrim, 1988), with the American Psychiatric Association 
acknowledging in 1980 that “the limits of the concept of schizophrenia are unclear” 
(APA, 1980, p.181). Some researchers have argued strongly for a continuum 
approach as opposed to the traditional categorical approach, for example Van Os and 
Reininghaus (2016) argue for the existence of an “extended and transdiagnostic 
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phenotype” of psychosis in the general population. These arguments are based on the 
acknowledged limitations of diagnosis of psychotic disorders which have been 
shown to have limited reliablilty and validity.  A study by Bromet et al.  (2005) 
found that 93.5% of people in their sample who had received a diagnosis of 
schizophrenia retained that diagnosis 10 years later, while only 28.6% of people in 
their sample retained a diagnosis of schizoaffective disorder 10 years later. Using 
DSM-5 criteria, Regier et al. (2013) found that raters achieved a Cohen’s kappa 
coefficient of 0.39 – 0.50 for schizophrenia and schizoaffective disorder (fair to 
moderate agreement as defined by Landis & Koch (1977)). The validity of using 
diagnostic labels for psychotic experiences has been called into question by research 
which has found that specific psychotic experiences exist on a continuum in the 
general population (Beavan et al., 2011; vanOs, 2003), that psychotic symptom types 
are not in themselves strong associates of schizophrenia (Goldman et al., 1992), and 
that there is considerable overlap between diagnostic categories that are presented in 
diagnostic frameworks as discrete entities (Reininghaus et al., 2016). In addition 
there have been several other frameworks proposed for understanding psychotic 
experiences that do not include an illness or diagnosis framework, for example 
emancipatory explanations (Romme & Escher, 1989), or psychological explanations 
(Garety et al., 2001; Morrison, 2001). Most of the research on decision making 
capacity in people who have experienced psychosis has been carried out with people 
who have received a diagnosis of schizophrenia or other psychotic disorder using a 
categorical model under the assumption that these labels are a reliable and valid 
indicator of the sample having experienced psychosis.  
Although people diagnosed with psychotic disorder are more likely than people 
diagnosed with non-psychotic mental health conditions to be judged to lack TDMC 
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(Okai et al., 2007; Owen et al., 2009), such a diagnosis is neither necessary nor 
sufficient for a judgement of decisional incapacity. Jeste et al. (2006) found that the 
prevalence of incapacity in psychosis varied between 10% and 52%, and published 
studies demonstrate substantial heterogeneity in incapacity within both psychotic and 
non-clinical populations (Jeste, Depp, & Palmer, 2006).  Nonetheless, some research 
suggests diagnostic status may moderate the relationship between 
psychopathological variables and capacity (Candia & Barba, 2011). For example, 
Owen et al. (2009) found that insight was the best discriminator of capacity status in 
people diagnosed with psychotic disorders and bipolar disorder, but not in non-
psychotic disorders.  
In summary, the concept of TDMC has become increasingly relevant to health care 
professionals and users of mental health services. Identifying those factors that are 
associated with TDMC in psychosis may help us develop a clinically useful 
theoretical model, which in turn will aid the development of effective interventions 
to support capacity. Thus, the primary objective of this systematic review is to 
identify which clinical and demographic variables are associated with treatment 
decision-making capacity in psychosis and, where a sufficient number of comparable 
studies exist, use meta-analysis and a systematic assessment of study and outcome 
quality to produce pooled estimates of the significance, magnitude and reliability of 
any relationship.  
Method 
To minimise the risk of selective reporting bias and maximise transparency, a 
protocol for the systematic review was registered in advance with the PROSPERO 
International Prospective Register of Systematic Reviews (Larkin & Hutton, 2015; 
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registration number: CRD42015025568). The protocol was updated to include a 
quantitative synthesis of effect sizes using meta-analytic procedures where three or 
more studies provided usable data, and incorporation of GRADE to assess outcome 
quality (Guyatt et al., 2008).  
Eligibility criteria 
As shown in Table 1, studies were included if they were published in English before 
October 2015, included a reliable and valid assessment of TDMC with adults 
diagnosed with a non-affective psychotic disorder and provided data on the 
association between TDMC and at least one other clinical or demographic variable. 
Assessment of TDMC was accepted as valid if participants had been asked to make a 
real or hypothetical decision about a health care or treatment decision, and if a valid 
and reliable tool was used to measure at least one of the accepted domains of 
decisional capacity: understanding, appreciation, communicating a choice, and 
retaining the memory of the decision. Any study reporting usable cross-sectional or 
longitudinal data was eligible for inclusion, regardless of study design. Studies were 
excluded where the proportion of participants with non-affective psychosis was less 
than 50% or where TDMC was not measured using a valid or reliable assessment. 
Since we are specifically investigating correlates of treatment decision-making 
capacity, and because capacity is a decision-specific concept, we excluded studies 
where only capacity to consent to participate in research or legal proceedings was 
examined. 
Search strategy 
A search using the terms (Schizo* OR Psychosis) AND (Capacity OR Decision 
making OR Consent) AND (Treatment OR Health care) was conducted in the 
20 
 
databases Embase, Embase Classic, Medline, and PsycInfo from 1947 to October 
2015. One researcher (AL) conducted the search (with support and training from a 
qualified librarian), and another (PH) provided supervision and consultation in the 
case of any uncertainty. The full search strategy is provided in Appendix A. Previous 
reviews and included studies were hand searched for additional studies, and authors 
were contacted for any further unpublished studies.  
Study selection 
The titles and abstracts of studies identified by the search were screened to eliminate 
obviously irrelevant studies (e.g. studies of unrelated conditions, or other reviews). 
The full-text reports for any remaining studies were then examined to determine 
eligibility against the inclusion and exclusion criteria.  
Table 1. Inclusion and exclusion criteria 
Category Criteria 
  
Study population Population consisted of people who had been diagnosed 
with a non-affective psychotic disorder (ICD-10 F20 – 
F29 diagnoses). Studies that used a mixed population 
were included if  >50% of the population was people 
diagnosed with non-affective psychotic disorders.  
Study geography Studies from all countries were accepted if they had 
used a definition of capacity that included at least one of 




Factors / Interventions  Any factors that were measured using a valid measure 
and had been assessed as contributing to treatment 
decision-making capacity were included. Baseline and 
change data from studies of interventions designed to 
enhance treatment decision-making capacity, or studies 
which had assessed treatment decision-making capacity 
pre- and post-intervention were included.  
Time period Studies published between 1947 and October 2015 were 
included in the review.  
Publication language Studies published in the English language only were 
included in the review.  
Admissible evidence 
(study design and other 
criteria)  




In line with previous systematic reviews (Taylor, Hutton and Wood, 2015; Dudley, 
Taylor, Wickham & Hutton, 2016), the assessment of observational study quality 
was conducted using an adapted version of the Agency for Healthcare Research and 
Quality assessment tool (Williams et al., 2010). The adequacy of the methods used to 
select the cohort, the sample size, the methods used to assess outcomes, the degree of 
missing data, and the appropriateness of the analytic methods used were all assessed 
as “yes”,”no”, “partial” or ‘can’t tell’ (see Appendix B). Randomised controlled 
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trials were assessed using the well-established Cochrane Risk of Bias tool (Higgins 
& Green, 2011), which assesses risk of selection, performance, detection, attrition 
and reporting biases (see Appendix C).  
An adapted version of GRADE (Grades of Recommendation, Assessment, 
Development, and Evaluation) (Guyatt et al., 2008) system was used to assess the 
quality of the effect size estimates, whether derived from single studies or groups of 
studies. Whether this was judged to be high, moderate, low or very low is based on 
consideration of overall study quality (as determined by AHRQ ratings) as well as 
consistency and precision of the effect size estimate, the directness of the outcome 
and degree of publication bias (Brozek et al., 2009). GRADE was applied to both 
pooled estimates derived from meta-analysis, as well as individual study estimates 
where meta-analysis was not possible. Criteria for assessing outcome quality within 
the GRADE approach are outlined in Appendix D.  
In reviews examining causal hypotheses (i.e., the effect of treatments) the GRADE 
approach rightly requires raters to automatically rate evidence from randomised 
controlled trials as high initially, and correlational (observational) studies as low 
initially. However GRADE has been adapted to examine the strength of evidence for 
other questions (Williams et al, 2010; Dudley et al., 2015). As noted elsewhere 
(Dudley et al., 2015), it would not be logical to apply such automatic downgrading to 
a review, such as ours, which seeks to examine the strength of evidence for and 
against a correlational hypothesis since this, by definition, depends on correlational 
studies. As such, outcome quality was initially rated as high, prior to downgrading 





Meta-analysis was conducted when at least three studies reported usable data on the 
relationship between a particular variable and treatment decision-making capacity. 
Meta-analyses were conducted using MetaXL software (EpiGear International, 2010 
– 2015). Correlations were transformed into Fisher’s Z, and a random effects model 
using the DerSimonian and Laird method was used to compute an overall effect size, 
together with 95% confidence intervals. This approach allows for true heterogeneity 
in effect size magnitude (due to differences in measurement, sample, etc.) to be 
distinguished from sampling error (Borenstein et al., 2009). Fisher’s Z estimates 
were then back-transformed to Pearson’s r to allow interpretation according to 
Cohen’s (1988) conventions (0.1 = small; 0.3 = moderate; 0.5 = large). 
The data presented in some studies did not follow a normal distribution, as indicated 
by the use of non-parametric statistics. Due to the small number of studies identified 
for each variable it was decided to pool the parametric and non-parametric data in the 
meta-analysis. Although we can assume that the underlying assumption of normality 
has been violated, the random effects model is adequate for estimating effect size - 
although the predictive power of the model is less (Karabatos, Talbott, & Walker, 
2014).  
Results  
Study selection  
The process of study selection is represented in the PRISMA diagram below (Fig. 1). 
Of the 2,057 papers initially identified, 1,993 were excluded after inspection of title 
or abstract. Full-text publications were sought for the remaining 64 papers. Of these, 
40 were excluded; 16 did not include a measure of capacity, 11 were case 
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descriptions or editorials, 4 examined a different population, 6 did not measure 
capacity as an outcome variable, 2 examined research decision making capacity and 
1 was a duplicate study. A full list of excluded studies with reason for exclusion is 
contained in Appendix E.  
A total of 24 studies were included for review. Study characteristics are provided in 
Table 2. The included studies provided data on the relationship between TDMC and 
symptoms (k=12), insight (k=4), affect (k=3), cognitive performance (k=6), 
executive functioning, (k=2), duration of illness (k=2), education (k=5), 
metacognition (k=1) and various interventions (k=10).  
Risk of bias  
AHRQ ratings of observational studies and uncontrolled or non-randomised 
intervention studies are provided in Tables 3 and 4 respectively. Table 5 provides the 
















Records identified through other 
sources  Hand search: 30 
Author contact: 16 
 
Records identified through 
database search:  2011 
Included studies: 24 
Studies excluded 
based on full text 
review: 40 
 
No usable measure of 
capacity: 22 
Not psychosis: 5 
Research capacity 
only: 2 
Case study or opinion 
piece: 11 
Duplicate: 1 
Full text articles assessed for eligibility: 64 
Excluded according 
to title or abstract: 
1993 
Records screened by reviewer: 2057 
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Table 2. Characteristics of included studies 
Authors, 
year, country 





system used  
Measure of 
capacity used 
Outcome measures used 
       
Cairns et al. 
(2005) 
England 
Observational General adult 
psychiatric ward 
112 (63.4% Male; Depression 
22.3%; Psychosis 55.4%; BPAD 
18.8%; Other 3.6%) 








MacCAT-T Brief Psychiatric Rating Scale 
(BPRS)  
Expanded Schedule for the 
Assessment of Insight (SAI-E)  
Mini Mental State Examination 
(MMSE) 
Brief Perceived Coercion Scale 
(BPCS)  
Capdevielle et 
al.  (2009)  
France 
Observational  Adult psychiatry 
outpatients  
60 (72% Male; Schizophrenia 
100%)  
Mean age: 36.3 (10.9)  
Diagnoses 
established by 
using the Patient 












research team.  
Mac-CAT-T  Scale to Assess Unawareness 
of Mental Disoder (SUMD)  
Beck Depression Inventory – 
2nd Ed. (BDI-II)  
Spielberger State Trait Anxiety 











system used  
Measure of 
capacity used 
Outcome measures used 
       
Di & Cheng 
(2013)  
China 
Observational  Adult psychiatric 
inpatients from 
two hospitals  
192 (81.2% Male; Diagnosis: 
Schizophrenia 100%)  
Mean age: 30.14)  
Diagnoses made 
by clinical team 
using DSM-IV 







Brief Psychiatric Rating Scale 
(BPRS)  
 
Dornan et al. 
(2015)  
Ireland  
Cohort  Secure forensic 
hospital  
37 (91.8% Male: Diagnosis: 
Schizophrenia 83.8%; 
Schizoaffective disorder  5.4%; 
BPAD 5.4%; Depression with 
pscyhotic features 2.7%; Psychotic 
disorder due to use of psychoactive 
substances 2.7%)  
Mean age: 32.3  
Diagnoses made 




IV TR criteria 
(APA, 2000) 
MacCAT-T Positive and Negative 
Symptom Scale (PANSS)  
Global Assessment of 
Functioning (GAF)  
Elbogen et al. 
(2007) 
USA 
RCT Two community 
mental health 
programmes 
469 (40% Male; Diagnosis; 
Schizophrenia: 59%; BPAD: 27%; 
Depression with psychotic features: 
14%)  














Brief Psychiatric Rating Scale 
(BPRS)  
Global Assessment of 
Functioning (GAF)  
Insight and Treatment 
Attitudes Questionnaire 
(ITAQ)  
American National Reading 
Test (AMNART)  
Similarities subscale from the 
Wechsler Adult Intelligence 
Scale – Third Edition (WAIS-
III)  
Controlled Oral Word 
Association Test (COWAT)  











system used  
Measure of 
capacity used 
Outcome measures used 





Observational  Adult acute 
psychiatric ward  
26 (Male 69%; Diagnosis: 
Schizophrenia and Schizoaffective 
disorder)  












Brief Psychiatric Rating Scale 
(BPRS)  
Beck Depression Inventory 
(BDI)  
Vocabulary, Similarities, and 
Digit Span subtests of the 
Wechsler Adult Intelligence 





Observational  Adult acute 
psychiatric ward 
75 (Male: 52%; Diagnosis: 
Schizophrenia or Schizoaffective 
disorder)  


















Brief Psychiatric Rating Scale 
(BPRS)  
Beck Depression Inventory 
(BDI)  
Vocabulary, Similarities, and 
Digit Span subscales from 
Wechsler Adult Intelligence 






Observational  Two adult 
psychiatric 
inpatient units  
40 (80% Male; Diagnosis: Paranoid 
Schizophrenia 40%; Schizophrenia 
30%; Schizoaffective disorder; 28%; 
Disorganized Schizophrenia 2%)  





















system used  
Measure of 
capacity used 
Outcome measures used 
       






61 (Male 38%; Diagnosis: 
Schizophrenia and schizoaffective 
disorder)  










Howe et al. 
(2005)  
Australia 
Observational  Two public 
treatment 
facilities  
110 (Male; 49.1%; Diagnosis: 
Schizophrenia 58.2%; 
Schizoaffective disorder 22.7%; 
BPAD 19.1%)  









using a modified 






Version) (SCID)  
MacCAT-T  Positive and Negative 
Syndrome Scale (PANSS) 
Kennedy et al. 
(2009)  
Ireland  
Cohort  Secure forensic 
hospital  
88 (Male: 90.9%: Diagnosis; 
Schizophrenia 69.3%; Depression 
with psychotic features 17.0%; 
Psychotic disorder due to substance 
misuse 5.7%; Schizoaffective 
disorder 4.5%; BPAD 3.4%)  







IV TR criteria 
(APA, 2000) 










system used  
Measure of 
capacity used 
Outcome measures used 
       
Koren et al. 
(2005)  
Israel  
Observational  Mental health 
centre 
21 (Male 61.9%: Diagnosis: 
Schizophrenia or schizophreniform 
disorder)  






(First et al., 
1997), a 
systematic 
review of the 




MacCAT-T Wisconsin Card Sorting Test 
(WCST)  
Rating of confidence in answer 
(0-100)  
Accuracy score 
Free choice improvement  
Monitoring resolution  
Control sensitivity  
Monetary gains 
Similarities and Block design 
subscales from Wechsler Adult 
Intelligence Scale-Revised  
Kleinman et 
al. (1996)  
Canada 
















al. (2012)  
France 
Observational  Psychiatric 
intensive care 
unit  
45 (Male: 44.4%: Diagnosis 
Schizophrenia / Schizoaffective 
Disorder 55.6%, Mood disorders 
37.8%; Other 6.7%)  
Mean age: 41 (13.1)  
Diagnoses made 





agreed at MDT 
meetings, and 




MacCAT-T  Brief Psychiatric Rating Scale 
(BPRS)  
Wisconsin Card Sorting Test 
(WCST)  











system used  
Measure of 
capacity used 
Outcome measures used 
       
Munetz & 





disorders clinic  
25 (Male: 44%: Diagnosis: 
Schizophrenia 88%; Other 12%)  
















 19 (Male: 100%: Diagnosis: 
Schizophrenia 78.9%; 
Schizoaffective disorder 15.8%; 
Major depression with psychotic 
features 5.3%)  







MacCAT-T   
Owen et al. 
(2011)  
UK  
Cohort  Three general 
adult psychiatric 
wards 
40 (Diagnosis: Schizophrenia or 







MacCAT-T Expanded Schedule for the 
Assessment of Insight (SAI-E)  
Matrix Reasoning subtest from 
Wechsler Abbreviated Scale of 
Intelligence (WASI)  
Brief Psychiatric Rating Scale 
(BPRS)  








40 (Diagnosis: Schizophrenia and 







MacCAT-T  Expanded Schedule for the 
Assessment of Insight (SAI-E)  
Matrix Reasoning subtest from 
Wechsler Abbreviated Scale of 
Intelligence (WASI)  











system used  
Measure of 
capacity used 
Outcome measures used 
       







16 (Male: 56.2%: Diagnosis: 
Schizophrenia 68.8%; 
Schizoaffective disorder 18.8%; 
BPAD 6.3%; Psychosis not 
otherwise specified 6.3%)  










Test (HCAT)  
Positive and Negative 
Syndrome Scale (PANSS)  
Brief Psychiatric Rating Scale 
(BPRS)  
Mattis Dementia Rating Scale 
(DRS)  
Raffard et al. 
(2013)  
France 
Observational  Outpatients at 
University 
Department of 
Adult Psychiatry  
60 (Male: 68.3%; Diagnosis: 
Schizophrenia 100% 










et al., 1997) by 
two independent 
psychiatrists.  
MacCAT-T  Beck Cognitive Insight Scale 
(BCIS)  
Beck Depression Inventory 
(BDI-II)  
Spielberger State Trait Anxiety  
Positive and Negative 
Syndrome Scale (PANSS)  
Rutledge et al. 
(2008)  
Ireland  
Observational  Secure forensic 
hospital  
102 (Male: 91.2%; Diagnosis 
Schizophrenia 81.4%; 
Schizoaffective disorder 6.9%; 
BPAD 7.2%; Psychotic Depression 
7.2%)  







MacCAT-T Positive and Negative 
Symdrome Scale (PANSS)  
Global Assessment of 










system used  
Measure of 
capacity used 
Outcome measures used 
       





59 (Male: 83%: Diagnosis: 
Schizophrenia 100%) 



















Brief Psychiatric Rating Scale 
(BPRS)  
Wong et al. 
(2000) 
UK  
Cohort   Local clinical 
services and GP  
19 (Male: 76%: Diagnosis 
Schizophrenia 90.5%; 
Schizoaffective disorder: 9.5%)  






















system used  
Measure of 
capacity used 
Outcome measures used 
       
Wong et al. 
(2005)  
Hong Kong 
Observational  Psychiatric 
hospital  
81 (Male: 54.3%: Diagnosis: 
Schizophrenia 100%)  






MacCAT-T Positive and Negative 
Syndrome Scale (PANSS)  
Montgomery and Asberg 
Depression Rating Scale 
(MADRS)  
Drug Attitude Inventory (DAI) 
Wechsler Adult Intelligence 
Test-Revised-Hong Kong 
version (WAIS-R-HK)  
Wisconsin Card Sorting Test 
(WCST)  
Wechsler Memory Scale 
(WMS)  
Monotone Counting Test 










Table 3. Risk of bias assessment in cross-sectional observational studies.  








































          
Cairns et al. 
(2005) 
Yes Yes No  Yes Yes Yes Can’t tell No Yes 
Capdevielle et al 
(2009) 
Yes Yes  Partial  Yes Yes Yes Yes No  Yes 
Di & Cheng 
(2013)  
Yes Yes No  Yes Yes Yes No No Yes 
Grisso & 
Appelbaum (1991)  
No  No No Yes Yes Yes Can’t tell  No  Yes 
Grisso & 
Appelbaum (1995)  





Yes Yes No  Yes Yes Yes No No  Yes 
Howe et al (2005)  No Yes No Yes Yes Yes Yes No  Yes 
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Koren et al (2005)  Yes Yes No Yes Yes Partial  Yes  No  Yes 
Mandarelli et al 
(2012)  
Yes Yes No  Yes Yes Yes Yes No Yes 
Owen et al (2009)  Yes Yes Partial Yes Yes Yes No Yes Yes 
Raffard et al 
(2013)  
Yes Yes No Yes Yes Yes Partial  Yes Yes 
Rutledge et al 
(2008) 
No  No  Partial  Yes Yes Yes No  No  Yes 
Schachter et al 
(1996)  
No Yes No Yes No Yes Yes Yes Yes 
Wong et al (2005)  No Yes No Yes No Yes No No Yes 





Table 4. Risk of bias assessment for non-randomised or uncontrolled intervention studies.  











































            
Dornan et al. 
(2015)  
No  No  No Yes Partial  Yes Partial Can’t 
tell 
Yes No Yes 
Kennedy et al. 
(2009) 
No  No  No Yes Yes Yes No Yes Yes No Yes 
Kleinman et al 
(1996) 
Yes Yes No Yes Yes No No No Yes No Yes 
Munetz & Roth 
(1985)  
Yes Yes No Yes Yes No No Yes Yes Yes Yes 
Naughton et al 
(2012)  
No No No Yes Yes Yes No No Yes Yes Yes 
Owen et al (2011)  Yes Yes No Yes N/A Yes No Yes Yes No Yes 
Palmer et al (2002)  No No No Yes Yes Yes Partial Yes No No  Yes 
Wong et al (2000)  No No No Yes Yes Yes Can’t 
tell  
Yes Yes No Yes 
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Table 5. Risk of bias assessment for randomised controlled trials.   
 







       
Elbogen et al (2007)  Yes Yes Unclear  No No  Yes 
Hamann et al (2011)  Yes Yes No  Yes No Yes 








Overall GRADE ratings for each outcome are presented in the right hand column of 
Tables 6 and 7. The majority of the studies suffered from a risk of bias in relation to 
participant selection, with most studies using convenience samples. Those assessing 
capacity were often not blind to participants’ outcomes on other variables included in 
the analysis. Funnel plots did not detect evidence of publication bias for the majority 
of the outcomes; however, there were generally too few studies to assess this 
(Ioannidis, 2005).  
Outcomes 
Symptoms (Figures 2-4) 
Pooled data from 9 studies (N=610) suggested there was a moderate to large negative 
association between total psychotic symptom severity, as assessed by total Brief 
Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962) or Positive and Negative 
Syndrome Scale (PANSS; Kay et al, 1987) scores, and the capacity of participants to 
understand information relevant to treatment decisions (r = -0.45, 95% CI -0.55, -
0.34; I
2
 60%; moderate quality evidence). All studies reported a negative correlation 
between symptom severity and understanding, although one study (Grisso et al. 
1997) reported a considerably smaller effect size. Removing this led to a larger 
correlation and lower heterogeneity (r = -0.49, 95% CI -0.39, -0.56; I
2
 46%). Data 
from 6 studies (N=453) suggested there was a small to moderate correlation between 
overall symptoms and the ability of participants to appreciate information relevant to 
a treatment decision (r = -0.23, 95% CI -0.14, - 0.32, I
2
 0%; low quality evidence). 
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Table 6. Summary of meta-analytical estimates 
Outcome and number of 
studies 
Included studies N 
Pooled Fisher’s Z (95% 
CI) 






      
Relationship between total 
symptom severity and 
understanding (9 studies)  
Capdevielle et al. (2009) 
Grisso & Appelbaum 
(1991)  
Grisso & Appelbaum 
(1995)  
Grisso & Appelbaum 
(1997) 
Howe et al. (2005)  
Raffard et al. (2013)  
Rutledge et al. (2008) 
Schacter et al. (1994)  
Wong et al. (2005)  
610 Z= -0.49 (-0.62, -0.35) 
r = -0.45 (-0.55, -0.34) 
 
60% Moderate (-1 risk of 
bias)  
Relationship between total 
symptom severity and 
appreciation (6 studies)  
Capdevielle et al. (2009)  
Grisso & Appelbaum 
(1997)  
Howe et al. (2005)  
Raffard et al. (2013)  
Rutledge et al. (2008)  
Wong et al. (2005)  
453 Z = -0.24 (-0.33, -0.14)  
r = -0.23 (-0.14, - 0.33) 
0% Low (-2 risk of bias)  
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Outcome and number of 
studies 
Included studies N 
Pooled Fisher’s Z (95% 
CI) 






Relationship between total 
symptom severity and 
reasoning (7 studies)   
Capdevielle et al. (2009)  
Grisso & Appelbaum 
(1995)  
Grisso & Appelbaum 
(1997)  
Howe et al. (2005) 
Raffard et al. (2013)  
Rutledge et al. (2008)  
Wong et al. (2005)  
528 Z = -0.32 (-0.52, - 0.12)  
r =  -0.31 (-0.48, - 0.12)  







understanding (3 studies) 
Capdevielle et al. (2009)  
Grisso & Appelbaum 
(1991)  
Raffard et al. (2013)  
146 Z = -0.04 (-0.21, 0.13)  
r = -0.04 (-0.20,  0.13)  
0% Moderate (-1 
imprecision)  
Relationship between verbal 
IQ and understanding (4 
studies) 
Grisso & Appelbaum 
(1991)  
Grisso & Appelbaum 
(1995)  
Koren et al. (2005)  
Wong et al. (2005)  
203 Z = 0.45 (0.20, 0.69)  
r = 0.42 (0.20, 0.60)  
60% Low (-1 risk of bias, 
-1 indirectness) 
Relationship between verbal 
IQ and reasoning (3 studies)  
Grisso & Appelbaum 
(1995)  
Koren et al. (2005)  
Wong et al. (2005) 
177 Z = 0.42 (0.27, 0.57)  
r = 0.39 (0.26, 0.51)  
0% Low (-2 risk of bias)  
Relationship between years 
of education and 
understanding (3 studies)  
Capdevielle et al. (2009) 
Raffard et al. (2013)  
Wong et al. (2005) 
201 Z = 0.49 (0.35, 0.63)  
r = 0.46 (0.34, 0.56) 





Outcome and number of 
studies 
Included studies N 
Pooled Fisher’s Z (95% 
CI) 






Relationship between years 
of education and reasoning 
(3 studies)  
Capdevielle et al. (2009) 
Raffard et al. (2013)  
Wong et al. (2005) 
201 Z = 0.26 (0.12, 0.40)  
r = 0.26 (0.12, 0.38)  
0% Moderate (-1 risk of 
bias) 


































    ES (95% CI)          % Weight
  -0.78  ( -0.97, -0.58)     13.4
  -0.71  ( -1.12, -0.30)      6.8
  -0.63  ( -0.89, -0.37)     11.0
  -0.55  ( -0.77, -0.33)     12.4
  -0.49  ( -0.62, -0.35)    100.0
  -0.46  ( -0.72, -0.20)     11.0
  -0.44  ( -0.67, -0.20)     12.1
  -0.38  ( -0.57, -0.19)     13.7
  -0.32  ( -0.59, -0.05)     10.7













    ES (95% CI)          % Weight
  -0.33  ( -0.55, -0.11)     17.9
  -0.28  ( -0.54, -0.02)     13.1
  -0.28  ( -0.47, -0.08)     22.8
  -0.24  ( -0.33, -0.14)    100.0
  -0.22  ( -0.41, -0.03)     24.6
  -0.11  ( -0.37,  0.15)     13.1
















    ES (95% CI)          % Weight
  -0.83  ( -1.03, -0.63)     15.3
  -0.38  ( -0.60, -0.15)     14.7
  -0.32  ( -0.52, -0.12)    100.0
  -0.26  ( -0.49, -0.02)     14.5
  -0.24  ( -0.50,  0.01)     13.8
  -0.22  ( -0.41, -0.03)     15.5
  -0.13  ( -0.39,  0.13)     13.8










    ES (95% CI)          % Weight
  -0.11  ( -0.52,  0.30)     16.8
  -0.11  ( -0.37,  0.15)     41.6
  -0.04  ( -0.21,  0.13)    100.0
   0.06  ( -0.20,  0.32)     41.6



























According to data from 7 studies (N=528) there was a moderate correlation between 
total symptoms and the ability of participants to reason in relation to treatment 
decision-making (r = -0.31, 95% CI -0.48, - 0.12, I
2
 80%; very low quality evidence). 
There was a high degree of heterogeneity in the results, which appeared to be 
attributable to the very large correlation reported by Rutledge et al. (2008), a study of 
forensic inpatients. Removing this study removed the heterogeneity and also lowered 
the effect size (r = -0.24, 95% CI -0.33, -0.14, I
2
 0%).  
Depression (Fig.5)   
There was no evidence that depression was associated with the ability of participants 
to understand information about their treatment, although the estimate was low in 
quality due to imprecision and risk of bias (k=3, N=146, r=-0.04, 95% CI -0.20, 0.13, 
I
2
 0%; moderate quality evidence).  
Cognitive and intellectual performance (Figures 6 &7) 
Moderate to large associations were observed between verbal cognitive functioning 
(assessed using subtests from the WAIS) and the ability of participants to understand 
information relating to treatment decision-making (k=4, N=203, r = 0.42, 95% CI 
0.20, 0.60; I
2 
60%; moderate quality evidence), and use reasoning (k=3, N=177, 
r=0.39, 95% CI 0.26, 0.51; I
2
















    ES (95% CI)          % Weight
   0.19  ( -0.27,  0.65)     16.9
   0.27  (  0.04,  0.50)     31.4
   0.45  (  0.20,  0.69)    100.0
   0.62  (  0.21,  1.03)     19.5
   0.65  (  0.43,  0.87)     32.1









    ES (95% CI)          % Weight
   0.29  ( -0.17,  0.75)     10.7
   0.41  (  0.18,  0.64)     42.9
   0.42  (  0.27,  0.57)    100.0
   0.45  (  0.23,  0.67)     46.4
































Figure 9: Forest plot of Fisher’s z effect sizes for years of education and 
reasoning 











    ES (95% CI)          % Weight
   0.44  (  0.18,  0.70)     29.7
   0.45  (  0.19,  0.71)     29.7
   0.49  (  0.35,  0.63)    100.0





Raffard 2013  
Wong 2005  
Overall 
Q=1.27, p=0.53, I2=0%
Capdevielle 2009  
    ES (95% CI)          % Weight
   0.17  ( -0.09,  0.43)     29.7
   0.23  (  0.01,  0.46)     40.6
   0.26  (  0.12,  0.40)    100.0
   0.38  (  0.12,  0.64)     29.7
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Years of education (Figures 8 & 9) 
High quality evidence suggested a large association between years spent in education 
and the ability of participants to understand information relating to treatment 
decisions (k=3, N=201, r=0.46, 95% CI 0.36, 0.56; I
2
 0%). The association between 
years of education and participants’ reasoning ability was small to moderate in 
magnitude (k=3, N=201, r=0.26, 95% CI 0.12, 0.38; I
2
 0%; moderate quality 
evidence).  
Executive functioning  
In a small study, Koren et al (2005) did not find clear evidence that executive 
functioning was associated with TDMC. The correlations that were observed were 
non-significant and small to moderate in magnitude; understanding (r = -0.35, 95% 
CI -0.68, 0.10 for trials to first category), appreciation (r = 0.41, (95% CI -0.03, 0.72 
for numbers of categories), and reasoning (r = 0.31, 95% CI -0.14, 0.65 for number 
of categories). Mandarelli et al (2012) found that poor executive functioning was 
associated with lower ratings on all MacCAT-T domains, understanding (Cohen’s d 
= 1.07, 95% CI 0.44, 1.71), appreciation (Cohen’s d = 1.07, 95% CI 0.44, 1.71), and 
reasoning (Cohen’s d = 0.32, 95% CI-0.28, 0.92). The inconsistent and imprecise 
findings meant the overall quality of evidence was rated as low.  
Insight  
Four studies examined the relationship between insight and treatment decision 
making capacity. Each assessed different aspects of insight, so were not conceptually 
similar enough to combine in meta-analysis. Capdevielle et al (2009) used the Scale 
to Assess Unawareness of Mental Disorder (SUMD) and found negative correlations 
between the five subscales and all domains of the MacCAT-T. For the mental 
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disorder subscale, there was a significant negative correlation with understanding (r 
= -0.34, 95% CI -0.55, -0.09) appreciation (r = -0.75, 95% CI -0.84, -0.61), reasoning 
(r = -0.74, 95% CI -0.84, -0.60), and expressing a choice (r = -0.41, 95% CI -0.60, -
0.17).  For the medication subscale there was a significant negative correlation with 
understanding (r = -0.38, 95% CI -0.58, -0.14), appreciation (r = -0.80, 95% CI -0.88, 
-0.69), reasoning (r = -0.72, (-0.82, -0.57) and expressing a choice (r = -0.35, 95% CI 
-0.55, -0.11). For the consequences subscale there was a significant negative 
correlation with understanding (r = -0.34, 95% CI -0.55, -0.09), appreciation (r = -
.74, 95% CI -0.84, -0.60), reasoning (r = -0.69, 95% CI -0.80, -0.53), and expressing 
a choice (r = -0.44, 95% CI -0.62, -0.21). The awareness subscale was significantly 
negatively correlated with understanding (r = -0.32, 95% CI -0.53, -0.07), 
appreciation (r = -0.63, 95% CI -0.76, -0.45), reasoning (r = -0.61, 95% CI -0.75, -
0.42) and expressing a choice (r = -0.34, 95% CI -0.55, -0.09). The attribution 
subscale was significantly negatively correlated with understanding (r = -0.39, 95% 
CI -0.59, -0.15), appreciation (r = -0.67, 95% CI -0.79, -0.50), reasoning (r = -0.63, 
95% CI -0.76, -0.45) and expressing a choice (r = -0.38, 95% CI -0.58, -0.14). 
Raffard et al (2013) used the Beck Cognitive Insight Scale (BCIS) found that self-
reflectiveness was significantly associated with reasoning ability (r = 0.43, 95% CI 
0.20, 0.63).  Owen et al (2009) used the Expanded Schedule for the Assessment of 
Insight (SAI-E) and found a very large significant difference in insight between those 
who were judged to have and not have intact TDMC (Hedge’s g =-2.19 95% CI-1.83, 
-2.55). Finally, Elbogen et al (2007) used the Insight and Treatment Attitudes 
Questionnaire (ITAQ) and again found that insight was positively and significantly 
associated with reasoning (β = 0.36, p <0.05). Although the evidence is consistent 
with the view that insight is associated with improved TDMC, in particular reasoning 
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ability, the quality of the evidence was judged to be low in quality overall because of 
risk of bias, and indirectness. 
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Table 7. Summary of individual observational study findings  
Correlate (number 
of studies)  
Studies included  N Outcome measures used Key findings 
Quality 
(GRADE)  
      
Executive functioning  
(2 studies)  
Koren et al. (2005)  
Mandarelli et al. (2012)  
66 Wisconsin Card Sorting Test 
(WCST)  
 
Some evidence of large 
correlations in one study, 
but no clear evidence in 
other. 





Cairns et al. (2005)  
Capdevielle et al. 
(2009)  
Owen et al. (2009)  
Raffard et al. (2013) 
Elbogen et al (2007) 
813 Scale to Assess Unawareness of 
Mental Disorder (SUMD) 
Expanded Schedule for the 
Assessment of Insight (SAI-E) 
Beck Cognitive Insight Scale (BCIS) 
Insight and Treatment Attitudes 
Questionnaire (ITAQ) 
Insight strongly and 
significantly associated 
with TDMC, and reasoning 
in particular 
Low (-1 risk of 
bias, -1 
indirectness)   
Duration of illness  
(2 studies)  
Raffard et al. (2013)  
Wong et al. (2005)  
141 Years since diagnosis  No clear evidence of 
association with TDMC  
Moderate (-1 risk 
of bias) 
Metacognitive ability 
(1 study)  
Koren et al. (2005) 21 Participant ratings of confidence in 
the correctness of the sort (0-100) 
Some evidence that 
metacognitive ability is 
associated with TDMC 
 
Perceived coercion Cairns et al. (2005)  112 Brief Perceived Coercion Scale 
(BPCS)  
Participants judged to have 
impaired capacity were 
more likely to report high 
perceived coercion 
 
Anxiety  Capdevielle et al. 
(2009)  
Raffard et al. (2013)  
 
120 Spielberger State- Trait Anxiety 
Inventory (STAI Trait and STAI 
State)  
Both state and trait anxiety 
had a small to medium 
positive correlations with 
appreciation and reasoning, 
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Table 8. Summary of individual intervention study findings  
      
Interventions  Studies included  N Outcome measure used Key findings Quality (GRADE)  
      
Altering presentation 
of material  
(5 studies)  
Kennedy et al. (2009)   
Kleinman et al. (1996)  
Munetz & Roth (1985)  
Palmer et al. (2002)  
Wong et al. (2000)  




Some evidence that 
extra information 
reduces capacity. 
Low (-2 risk of bias) 
Treatment as usual 
and medication 
(2 studies)  
Dornan et al. (2015)  
Owen et al. (2011)  





Low (-2 risk of bias)   
Shared decision 
making (SDM) 
(2 studies)  
Elbogen et al. (2007)  
Hamann et al. (2011) 
442 Change in capacity scores SDM caused improved 
capacity in one trial, but 
not another 
Low (-1 risk of bias, 
-1 inconsistency) 
Metacognitive training  
(1 study)  
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Duration of illness 
Two studies provided moderate quality data on the relationship between duration of 
illness and TDMC (Raffard et al. 2013; Wong et al., 2005). Both reported non-
significant small negative correlations between duration of illness and the 
understanding domain of the MacCAT-T (Raffard et al, 2013; r = -0.12, 95% CI -
0.36, 0.14; Wong et al., 2005; ρ = -0.23, p > 0.05), and one reported non-significant 
small negative correlations between duration of illness and appreciation (r = -0.09, 
95% CI -0.34, 0.17), reasoning (r = -0.19, 95% CI -0.42, 0.06) and expressing a 
choice (r = -0.18, 95% CI -0.42, 0.08) (Raffard et al., 2013).  
Metacognitive ability  
In one small study, Koren et al (2005) found that metacognitive ability was 
significantly associated with the ability of participants to understand information 
relating to treatment (r = 0.60, 95% CI 0.23, 0.82 for control sensitivity). Although 
not significant, correlations of similar magnitude were observed for appreciation (r = 
0.40, 95% CI -0.04, 0.71 for monetary gains) and reasoning (r = 0.43, (95% CI -0.00, 
0.73), although these were not statistically significant.  
Perceived coercion 
Cairns et al. (2005) found that participants judged to have impaired capacity were 
more likely to report higher levels of perceived coercion (Mann-Whitney U = 422.5, 
p < 0.001).   
Anxiety  
Two studies reported positive correlations between state and trait anxiety and aspects 
of TDMC – i.e., greater anxiety was linked to greater treatment decisional capacity. 
54 
 
State anxiety was significantly correlated with the appreciation domain in both 
studies (r=0.27, 95% CI 0.02, 0.49; Capdevielle et al., 2009; r=0.36, 95% CI 0.12, 
0.56; Raffard et al., 2013), whereas trait anxiety was only significantly associated 
with appreciation in one (r=0.33, 95% CI 0.08, 0.54; Capdevielle et al., 2009; r=0.22, 
95% CI -0.04, 0.45; Raffard et al., 2013). A similar pattern of findings was observed 
for the relation between state anxiety and reasoning (r=0.32, 95% CI 0.07, 0.53; 
Capdevielle et al., 2009; r=0.27, 95% CI 0.02, 0.49; Raffard et al., 2013) and trait 
anxiety and reasoning (r=0.38, 95% CI 0.14, 0.58; Capdevielle et al., 2009; r=0.15, 
95% CI -0.11, 0.39; Raffard et al., 2013). In both studies, non-significant small 
correlations were reported for state and trait anxiety and understanding and 
expressing a choice.  
Interventions  
Of the 10 intervention studies we identified, 5 assessed the effect of altering the 
presentation of information on TDMC, 2 examined the effect of usual treatment, 2 
examined the effect of shared decision making, and 1 study examined the effect of 
metacognitive training.  
Altering presentation of material  
Repetition of information, and discussion of presented information with others, were 
associated with increases in TDMC in three studies (Kleinman et al., 1996; Munetz 
& Roth, 1985; Palmer et al., 2002). The effect size for completing an educational 
review process in Kleinman et al. (1996) was moderate (Cohen’s d = 0.27, 95% CI -
0.51, 1.06), and for formal presentation in Munetz & Roth (1985) was large (Cohen’s 
d = 1.83, 95% CI 0.48, 3.18). There was not enough data provided in Palmer et al. 
(2002) to calculate effect sizes, there was a statistically significant increase in scores 
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on the Hopkins Competency Assessment Test (χ
2
 = 12.05, N=13, p=0.002). 
However, Kennedy et al (2009) found that providing extra information to 
participants in a forensic setting was associated with a fall in TDMC, with a 
statistically significant proportion of the sample becoming incapable of making a 
treatment choice following the presentation of extra information (Cohen’s d = 0.75, 
95% CI 0.30, 1.20). Wong et al (2000) successively simplified the presentation of 
information and found that as the task was simplified, TDMC improved significantly 
(Cochran’s Q = 14.4, df = 3, p < 0.01). Overall, the evidence on the effect of 
changing presentation of information was judged to be of low quality.  
Treatment as usual and medication 
Owen et al (2011) found that 37% of patients regained TDMC following a month of 
treatment in hospital. Recovery of TDMC was strongly associated with improved 
insight in this study (OR = 13.28).  
Dornan et al. (2015) found that patients receiving treatment as usual, which included 
25 hours per week of individual programmed activities, as well as treatment with 
antipsychotic medications, improved on all domains of TDMC – understanding 
(Cohen’s d = 0.62, 95% CI 0.15, 1.09), appreciation (Cohen’s d = 0.39, 95% CI-0.07, 
0.85), and reasoning (Cohen’s d = 0.63, 95% CI 0.16, 1.09). Dornan et al (2015) also 
found that patients treated with clozapine had larger improvements in TDMC than 
patients treated with other antipsychotics. This effect was largest and significant in 
the appreciation domain (Cohen’s d = 2.10, 95% CI 1.15, 3.05), and smaller and non-
significant in the understanding (Cohen’s d = 0.75, -0.09, 1.59) and reasoning 
domain (Cohen’s d = 0.71, 95% CI -0.13, 1.55). The evidence here was judged be of 
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low quality, and indicate that antipsychotic medication is associated with 
improvements in TDMC in some but not all individuals.  
Shared decision making  
Two methodologically strong studies examined the effect of a shared decision 
making (SDM) intervention on TDMC. However, these studies found conflicting 
results. Elbogen et al (2007) found a significant effect of SDM on reasoning 
(F(1,355) = 4.30, p <0.05), but not appreciation or understanding, whereas Hamann 
et al (2011) found a non-significant but negative effect on TDMC (Cohen’s d = -
0.34, 95% CI -0.85, 0.16). Elbogen et al (2007) reported a larger sample size than 
Hamann et al, and used a more established measure of treatment decision-making 
capacity. There was not enough information contained in the report of Elbogen et al. 
(2007) to calculate effect size.  
Metacognitive training  
Naughton et al (2012) found that patients who received group metacognitive (MCT) 
training had improved MacCAT-T scores. The effect sizes and confidence intervals 
were calculated and showed that MCT training had a significant effect on 
understanding (Cohen’s d = 1.44, 95% CI 0.42, 2.45) and reasoning (Cohen’s d = 
1.21, 95% CI 0.22, 2.20), but a smaller non-significant effect on the appreciation 
domain (Cohen’s d = 0.19, 95% CI -0.72, 1.10). A dose-response effect was 
reported, in that the more sessions attended, the greater the improvements in 
capacity. This early evidence from a small study (N=19) was rated as low in quality 





Summary of results 
Our primary objective was to identify which clinical, demographic and intervention-
related variables are associated with treatment decision-making capacity (TDMC) in 
psychosis, using meta-analysis where appropriate to estimate the significance and 
magnitude of any relationships. We identified 24 relevant studies, over half of which 
were published in the last 10 years. Overall, these reported data from 1,823 
individuals with psychosis.  
As might be expected, the variables studied most frequently were psychotic 
symptoms and cognitive ability. Good quality meta-analytical evidence confirmed 
that symptom severity was strongly associated with the ability of participants to 
understand treatment-relevant information, with smaller yet still significant 
associations with appreciation and reasoning. There was less evidence on the 
relationship between cognition and capacity, although moderate to large associations 
between verbal cognitive functioning and both reasoning and understanding emerged 
from the meta-analyses. There were similar findings for duration of education. 
Surprisingly, the relationship between capacity and emotion has not been studied in 
any great depth. However studies that do exist have found no evidence to suggest 
that depression is related to the ability to understand treatment-relevant information, 
and whether this is related to other components of TDMC remains unclear.  Two 
studies reported some surprising evidence that greater anxiety may be related to 
better appreciation and reasoning, but more evidence is needed to support this link.   
There was some evidence that aspects of executive functioning were related to 
TDMC, with emerging evidence that metacognitive awareness and insight (including 
58 
 
self-reflectivity) are associated with improved TDMC. Although we did not find 
clear evidence that duration of illness is linked to reduced TDMC, only two studies 
reported data on this outcome.  
There was also emerging evidence to suggest that various interventions, ranging 
from the simple to the more complex, may be associated with changes in how people 
with psychosis understand, appreciate, and reason with information related to health 
care and treatment decisions. The presentation of information may be an important 
consideration in interventions to support decision-making, and there was some 
evidence that simply providing extra information may actually hinder treatment 
decisional capacity in this group. Randomised controlled trials will be required to test 
these emerging hypotheses. Indeed, the only randomised controlled trial to use an 
established measure of TDMC found that a shared decision-making (SDM) approach 
significantly enhanced the successful use of reasoning in relation to treatment 
decision-making. On the other hand, there was no effect of SDM on understanding or 
appreciation in this large trial (N=469; Elbogen et al 2007). Although another smaller 
trial (N=61; Hamann et al 2006) found no benefit of SDM on TDMC, the researchers 
measured this using a less validated 10-point scale, which was rated by participating 
clinicians rather than independent researchers. 
Overall, this review has shown there is promising evidence that treatment decision-
making capacity may be responsive to intervention. On the other hand, it has been 25 
years since the first study of TDMC in psychosis, and we still lack robust evidence 






This review was broad in scope and to some extent exploratory, and we were limited 
by the studies that have been carried out. Nonetheless, we have provided a detailed 
snapshot of the available evidence on correlates and risk factors for impaired TDMC, 
and we have identified important gaps and weaknesses in the literature. The 
correlational nature of much of the data precludes causal interpretations and 
experimental studies conducted within a causal-interventionist framework (Kendler 
& Campbell, 2009) are required to develop and test a theoretical model of TDMC in 
psychosis. We have also only considered decision-making in relation to treatment 
decisions, which may confound the specific nature of the decision with the individual 
person’s capacities. Although this means our results have high clinical utility, there is 
a wealth of data on cognitive and neuropsychological factors involved in decision-
making ability in psychosis – for example, as measured by the Wisconsin Card 
Sorting Task (Wing et al., 2013). The development of a comprehensive theory of 
TDMC in psychosis will require integration and synthesis of this literature, but this 
was outwith the scope of the current review.  
Only a small number of studies were included in most of the meta-analyses. This 
limits the ability of the meta-analysis to detect between-study variance (Borenstein et 
al., 2009), publication bias (Ioannidis & Trikalinos, 2007) and smaller yet 
theoretically important effects. Nonetheless, as Sheskin (2003) states “one should 
view combined / pooled probability and effect size values computed in meta-analysis 
as rough estimates”.  
We focused on correlational data in this review, but arguably it is of greater clinical 
relevance to consider what distinguishes those judged to have TDMC and those who 
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do not. Although dichotomising continuous data in this way greatly diminishes 
statistical power to detect differences (Altman & Royston, 2006), it could be argued 
that TDMC is not continuously distributed. As with the ongoing debate over the 
relative merits of categorical or dimensional approaches to psychopathology (Lawrie 
et al., 2016), we suggest both approaches are likely to be useful.  
Some of the data used in the meta-analysis violated the assumption of normality, and 
we used an effect size converter to convert parametric and non-parametric 
correlations to Fisher’s Z effect size. This violation does reduce predictive power, 
but is still suitable for estimation of effect size in meta-analysis (Karabatos, Talbott, 
& Walker, 2014). 
Implications 
Relatively little research has focused on psychological mechanisms that may 
contribute to decision-making capacity in people who have experienced psychosis. 
The reasons for this are unclear. Although capacity is a legal concept, psychologists 
have been closely involved in its development and application in psychosis (Grisso 
& Appelbaum, 1991). Whatever the reason, we encourage further research into the 
role of reasoning biases (Kahnemen, 2003), attitudes and beliefs (Armitage & 
Conner, 2001), emotions such as fear or anxiety (Rogers, 1975; Hartley & Phelps, 
2012) values (Mukherjee & Kable, 2014) and the application of psychological 
models of healthcare decision-making. Such work will take us closer to developing 
an integrated model of TDMC in psychosis, and the development of effective 
psychological strategies to support it.   
Although we found a large association between total symptom severity and TDMC, 
only two studies identified for this review (Dornan et al., 2015; Owen et al., 2011) 
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explicitly measured treatment decision making capacity before and after treatment 
with antipsychotic medications. Given the link between ability to make treatment 
decisions and perceived autonomy and recovery, investigating how current 
treatments and interventions for psychosis impact on TDMC may be an important 
outcome for service users. Without such research, the hypothesis that 
pharmacological and psychological approaches improve TDMC remains untested. 
Most non-pharmacological intervention studies have focussed on altering the way 
information is presented as a means to increase TDMC. Further research should 
investigate more sophisticated interventions such as metacognitive training, and 
other psychological therapies. Improved decision-making ability is an outcome of 
interest to service users in a recovery-focused model of health care delivery – 
capacity and autonomy are closely linked and may be more important than reduction 
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Introduction: Cognitive biases and subjective recovery are a major focus of 
psychological approaches to psychosis, yet whether they are associated with 
domains of treatment decision making capacity (TDMC) is unknown. The 
current study tests the hypothesis that cognitive biases account for a significant 
amount of variance in TDMC after taking into account known predictors 
(symptoms, insight), and that higher TDMC is associated with greater 
subjective recovery.  
Method: Twenty-five participants diagnosed with non-affective psychosis 
completed measures of TDMC, psychotic symptoms and cognitive biases; 17 
also completed measures of cognitive insight and subjective recovery. 
Hierarchical multiple regressions and correlational analyses were used to test 
the main hypotheses.   
Results: Cognitive biases, ‘jumping to conclusions bias’ in particular, predicted 
a moderate amount of variance in the TDMC domains of ‘understanding’ and 
‘reasoning’, but did not add predictive power to a model containing symptoms, 
insight, and cognitive functioning. The appreciation domain was most strongly 
predicted by cognitive biases, insight, and cognitive functioning. The results 
suggest there may be more complex relationships between these variables. Post 
hoc analyses found that positive symptoms may mediate the relationship 
between cognitive biases and understanding; however there was no evidence 
that emotional distress mediated the effect of cognitive biases on TDMC. 
TDMC was not associated with subjective recovery in this sample.   
Conclusions: Psychosis-specific cognitive biases may be involved in TDMC in 
this group, but further research is required to clarify the exact nature of this 
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The ability to make informed and reasoned decisions is referred to as ‘having 
capacity’ to make those decisions, and is an essential component of informed consent 
for physical and mental health care interventions. The most widely accepted 
conceptualisation of capacity involves four key domains identified by the MacArthur 
Treatment Competence Study (Appelbaum & Grisso, 1995): understanding, 
appreciation, reasoning, and expressing a choice. These four domains are also used in 
the legal definition of capacity described in the Adults with Incapacity (Scotland) 
Act (2000) which defines incapacity as being incapable of (a) acting; or (b) making 
decisions; or (c) communicating decisions; or (d) understanding decisions; or (e) 
retaining the memory of decisions. 
These studies led to the development of the MacArthur Competence Assessment 
Tool for Treatment (MacCAT-T), which has the most empirical validation of all 
research tools in decision making capacity (Dunn et al., 2006). The MacCAT-T was 
designed to reflect important legal principles, and since then a number of studies 
have used it to investigate the role of clinical variables on capacity, (Capdevielle et 
al., 2009; Dornan et al., 2015; Owen et al., 2011). This is important as decisions 
about capacity to consent to treatment are made by clinicians in the majority of 
instances, however there is little consensus on the clinical aspects of capacity. In 
addition, most research has focused on stable characteristics or symptoms, rather 
than psychological factors (Okai et al, 2007). This research has shown that decision 
making capacity is related to cognitive impairment (Carpenter et al., 2000; Palmer et 
al., 2004; Stroup et al., 2005), level of insight (Maxmin et al., 2009; Ruissen et al., 
2012), diagnosis, particularly diagnosis of psychotic disorder (Okai et al, 2007) and 
manic episodes (Owen et al., 2009).  
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Studies have consistently shown that people who have a diagnosis of a psychotic 
disorder are more likely to be deemed incapable of making treatment decisions (Okai 
et al., 2007; Owen et al., 2009). This has led to emerging research on the specific 
aspects of psychotic experiences that influence such judgements. For example, it has 
been shown that the severity of general psychopathology in people with psychosis is 
inversely correlated with scores on measure of decision making capacity (Rutledge et 
al., 2008). More specifically, research has focused on whether positive or negative 
symptoms explain more of the variance in decision making capacity, although the 
results of these studies have been inconsistent, with some reporting that positive 
symptoms such as hallucinations are more significantly related (Owen et al., 2009, 
Rutledge, et al., 2008; Howe et al., 2005), and some other studies suggesting that 
negative symptoms and cognitive limitations have more of a role (Palmer & Salva, 
2007).  
 
The strong association between psychosis and decisional incapacity suggests the 
possibility that psychological factors involved in psychotic experiences may also 
negatively affect decision-making. Cognitive models of psychosis propose that 
specific cognitive biases contribute to the formation and maintenance of the positive 
symptoms of psychosis, such as delusions and hallucinations (Morrison, 2001; 
Garety et al., 2001; Freeman et al., 2002). There is a growing body of evidence 
showing that both cognitive and affective processes affect the development and 
maintenance of psychosis. A study by Freeman et al. in 2013 showed that current 
paranoid thinking was associated with anxiety, depression, greater anticipation of 
threat events, negative interpretations of ambiguous events, a self-focussed cognitive 
style, and negative ideas about the self. Attachment style (Berry, Barrowclough, & 
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Wearden, 2008), childhood adversity (Read et al., 2014), interpersonal schema 
(Birchwood et al., 2004), and metacognition (MacBeth et al., 2014; Lysaker et al., 
2005) have all been found to have a role in psychosis. Cognitive reasoning biases 
have been the most well researched of these psychological factors, and the most 
empirically validated of these is the jumping to conclusions (JTC) bias. A review by 
Garety and Freeman (1999) found that of 14 studies reviewed, 11 provided evidence 
for reasoning biases in people with delusions. In a recent meta-analysis of 55 studies, 
a robust association between overall psychotic symptoms and the JTC bias was 
observed, although this was only weakly associated with delusion severity (Dudley, 
Taylor, Wickham & Hutton, 2015). Other cognitive biases such as heightened self 
certainty, reduced theory of mind, and poor source memory have been found to be 
related to schizotypy (Sacks, Weisman de Mamani, & Garcia, 2012), and current 
paranoid thinking has been found to be related to hypervigilance, negative 
interpretations of events, self-focused cognitive style, and negative ideas about the 
self (Freeman et al., 2012).  
 
A variety of psychological therapies that focus on modifying cognitive biases in 
psychosis have been developed, including cognitive behavioural therapy (CBT). 
Although the promise of earlier forms of CBT have been challenged by meta-
analyses suggesting small benefits at best, there have been a number of recent 
developments that give grounds for optimism. These include evidence that CBT is 
effective at preventing psychosis in those at risk of developing it (Hutton & Taylor, 
2014), evidence that metacognitive training, an approach that targets cognitive biases 
specifically, appears to have a robust effect on positive symptoms (Moritz et al., 
2014; Eichner & Berna, 2016) and more recent evidence suggests brief reasoning 
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interventions focused on modifying the JTC bias can effect significant changes in 
delusion severity (Garety et al., 2015; Waller et al., 2015). Overall, it appears that 
cognitive biases in psychosis are amenable to change, and that reducing these biases 
may be linked to improved symptoms. 
 
The extent to which decisional capacity is amenable to psychological or 
pharmacological intervention remains unclear. Although a Delphi study carried out 
in 2010 by Morrison and Barratt, found that experts considered the statement “CBT 
should assist the maintenance of a client’s capacity to make informed decisions about 
their lives” to be one of the essential elements of CBT for psychosis, no research has 
examined its effects on capacity. Palmer et al. (2013) found that decisional capacity 
in research participants showed a general pattern of stability, however in a clinical 
sample of in-patients Owen et al. (2011) found that 37% of patients who were 
admitted without decision making capacity had regained capacity one month later. 
All who had regained capacity had improved on symptom scores, but an 
improvement in symptoms was not sufficient to have regained capacity. A small 
study by Naughton et al. (2012) used group meta-cognitive therapy (MCT) as an 
intervention with forensic patients with a psychotic illness. Although symptoms did 
not improve in this group, there was a significant change in mental capacity as 
measured by the MacCAT-T. Two randomised controlled trials have been conducted 
to assess the impact of shared decision making on assessments of capacity (Elbogen 
et al., 2007; Hamann et al., 2011). These trials found conflicting results, while 
Elbogen et al. (2007) found that an SDM intervention improved participants’ 
reasoning, while Hamann et al. (2011) found that an SDM intervention had no 
significant effect on overall capacity.  In summary, there is suggestive evidence that 
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treatment decisional capacity in psychosis might respond to treatment, but there is a 
lack of definitive evidence from randomised controlled trials.  
 
This lack of robust evidence is troubling, given the likely importance of capacity to 
people with psychosis and their clinicians. However whether capacity is associated 
with recovery as defined by users of mental health services is unclear. Although a 
recent Delphi study carried out with people who have experienced psychosis found 
that 86% endorsed the statement that “recovery is the process of regaining active 
control over one’s life” and 80% believed that “when other people are making 
decisions about the other person’s life” this is a factor that hinders recovery (Law & 
Morrison, 2014), to date no studies have examined whether there is a correlation 
between capacity and recovery in psychosis. Although it seems plausible that greater 
decisional capacity would be associated with greater subjective recovery from 
psychosis, it may also be the case the current concepts of capacity are, when applied 
by clinicians, underpinned by a model of psychosis (Shek et al., 2010) which some 
service users would not endorse (Pitt et al., 2007). 
 
Overall the research outlined above shows that people who experience psychosis are 
more likely to be deemed not to have capacity, that there remains unexplained 
variance in capacity in psychosis even after accounting for the contribution of 
symptoms, that there is good evidence that reducing cognitive biases leads to 
improvements in psychotic symptoms, that there is preliminary evidence that 
targeting cognitive biases is linked to improvements in decision making capacity, 
and that both clinicians and people who experience psychosis believe that retaining 
or regaining the ability to make decisions about one’s care is an important aspect of 
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recovery. Taken together, this evidence suggests two important hypotheses; first, that 
cognitive biases may help to explain additional variance in treatment decisional 
capacity in psychosis over and above that explained by psychotic symptoms and 
second, that greater treatment decisional capacity may be positively associated with 
greater self-reported recovery from psychosis. The aim of the current study is to test 




This study employed a cross-sectional within-group design. Individuals with 
psychosis were assessed at a single time-point using self-report questionnaires, 
structured interviews and other procedures. Ethical approval was granted by the West 
of Scotland NHS Research Ethics Committee and the University of Edinburgh, after 
which the study hypotheses and procedures were pre-registered on the Open Science 
Framework (Larkin & Hutton, 2014). Additional data was collected at baseline from 
participants taking part in an experimental study, which was running in parallel and 
administering the same measures to the same population. An initial power 
calculation was completed during the design of the research. It was predicted that 
using a large effect size, the study would require 46 participants (as calculated by 
G*Power) (Erdfelder, Faul, & Buchner, 1996) using an effect size of f = 0.35, α = 
0.05, and power = 0.80 with 6 predictors in a fixed model linear regression. Due to 
difficulties recruiting to the study, the planned power analysis was modified to test 
for a change in R
2






People were able to take part if they had a diagnosis of non-affective psychosis 
(ICD-10 F20 – F29 categories), were aged between 18 and 65 and were able to give 
informed consent to participating in research. Both self-referrals and referrals from 
clinical teams were accepted.  
Those who met these criteria were unable to take part if they had a co-morbid 
diagnosis of developmental disability, suffered a brain injury or neurological disease, 
had a primary diagnosis of substance misuse disorder, were non-English speaking (in 
so far as this prevented them from understanding the questionnaires), were 
experiencing a crisis or were suffering from acute distress. The inclusion and 
exclusion criteria were designed to ensure participation, within ethical parameters, of 
a representative sample of individuals with psychosis. Those with developmental or 
other comorbid disorders were excluded to increase the internal validity of the 
findings. Participants were recruited from three NHS Scotland Health Boards; NHS 
Dumfries and Galloway, NHS Lanarkshire and NHS Lothian, as well as a range of 
community and voluntary organisations in these areas. 
 
Procedure 
Purposive sampling was used to recruit individuals who were in contact with mental 
health services or third sector organisations. The researcher first presented the 
research to NHS mental health teams, voluntary organisations, support services and 
sheltered accommodation services, and permission was given to place posters 
advertising the study in prominent locations accessible by staff and / or patients. 
These organisations were asked to identify potential participants, provide them with 
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an information sheet, which contained full details about the study, and seek verbal 
consent for the researcher to contact them to discuss the study further.  
After confirming that interested individuals met inclusion and exclusion criteria, and 
after gaining consent to liaise with clinical staff for the purposes of risk assessment, 
the researcher then met with potential participants in a convenient NHS location to 
go through the information sheet and discuss the study further. At the second 
meeting participants’ capacity to make a decision about taking part in the research 
was assessed. Those still eligible were invited to sign a consent form and the study 
commenced. Potential participants could also self-refer to the study, as long as they 
provided verbal consent for the researcher to confirm with their clinical team that 
they met inclusion and exclusion criteria. Research interviews typically took between 
90 – 120 minutes, over the course of one or two meetings.  
Measures  
To characterise the sample, information was gathered on consenting participants’ 
age, gender, ethnicity, education, diagnosis, and illness history. Participants were 
then invited to complete the following assessments:  
MacArthur Competence Assessment Tool – Treatment (MacCAT-T)  
The Mac-CAT-T is considered the gold standard in the assessment of decision 
making capacity (Owens et al., 2009). It is a semi-structured interview that assesses 
treatment decision making capacity on four dimensions – understanding, 
appreciation, reasoning, and communication. The MacCAT-T is the most widely 
used measure of capacity in the literature. Cairns et al. (2005) found that the 
MacCAT-T produced reliable judgments of capacity, and that clinical judgments of 
capacity were highly related to Mac-CAT-T scores. The MacCAT-T has been found 
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to be reliable and valid and to have a high degree of inter-rater reliability (Grisso, 
Appelbaum, & Hill-Fotouhi, 1997).  
Positive and negative syndrome scale (PANSS) (Kay et al, 1987) 
The PANSS is a 30-item structured clinical interview. It was designed as a three 
factor measure to assess positive symptoms, negative symptoms, and general 
psychopathology. The PANSS is the most widely used measure for the assessment of 
the symptoms of schizophrenia, and has been demonstrated to have adequate 
psychometric properties (Kay et al., 1987; Peralta & Cuesta, 1993). Possible scores 
range from 30 to 210, with a score of 57-61 corresponding to mild illness, a score of 
75-78 corresponding to moderate illness, a score of 93-96 corresponding to marked 
illness, and scores of 115 and above corresponding to severe illness (Leucht et al., 
2005). Recently, the PANSS has been investigated as a five-factor measure, as 
opposed to its original three factor design (Rodriguez-Jiminez et al., 2013). For the 
purpose of the current research the PANSS was analysed as a five-factor measure, to 
allow for cognitive impairment to be used as a predictor variable. For exploratory 
analysis using a mediation model with a variable measuring emotional distress, the 
pentagonal factor structure of the PANSS (White et al., 1997) was used. The factor 
and item structure of each of these models of the PANSS is included in Appendix H.   
Cognitive Bias Questionnaire for Psychosis (CBQ-P) 
The CBQ-P is a 30-item measure designed to measure five cognitive biases – 
jumping to conclusions, intentionalising, catastrophizing, emotional reasoning, and 
dichotomous thinking. The CBQ-P has shown adequate psychometric properties, and 
has been shown to measure an overall thinking style (1-factor model) as well as 
having a reasonable fit for a 5-factor model, which assesses the cognitive distortions 
87 
 
as separate factors (Peters et al., 2013). The CBQ-P has been used to distinguish 
clinical and non-clinical voice hearers in a recent study (Daalman et al., 2013). 
Beck Cognitive Insight Questionnaire (BCIS) 
The BCIS is a 15-item self-report questionnaire that assesses self-reflectiveness and 
confidence in interpretation of experiences. Several independent groups have 
demonstrated that the BCIS is reliable, demonstrates convergent and construct 
validity, and distinguishes patients with psychosis from healthy controls and patients 
without psychosis (Riggs et al., 2010).  
Recovery Assessment Scale (RAS)  
The RAS is a 41-item self-report measure of dimensions of service-user defined 
recovery. It assesses five factors of recovery: hope, meaning of life, quality of life, 
symptoms, and empowerment. It has been found to be reliable and valid (Giffort et 
al., 1995). 
Probabilistic reasoning task “the beads task” 
The beads task (Phillips & Edwards, 1966) is an experimental task designed to 
examine individuals’ reasoning style under conditions of uncertainty.  It is based on a 
Bayesian model of probabilistic reasoning. It has been widely used in studies of 
people with psychosis and delusions and has been shown to demonstrate a “jumping 
to conclusions” (JTC) reasoning style, i.e. a tendency to make decisions based on 
insufficient information (Garety & Freeman, 1999; Freeman 2007; Dudley et al., 
2015). A computerized version of the task, as used by Garety et al. (2005) was 
shown to participants using MS PowerPoint. Variants of this task have used ratios of 
85:15 or 60:40. The current study used the 60:40 ratio. While the 85:15 version is 
simple and maybe more suitable for assessing patients with poor concentration, it 
may not produce sufficient variation in performance across well-functioning groups. 
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Those who require two or fewer draws to decision were categorized as evidencing 
the JTC bias (Dudley et al., 2015), meaning participants will be categorized as 
having or not having the JTC bias. This variable will be coded “0” or “1” to allow for 
it to be entered into the proposed regression as a dummy variable. 
 
All measures were administered by AL, who received training and supervision in 
administration of both the MacCAT-T and PANSS. Anonymised data from the 
second study was collected by a second researcher (DT), who had also received 
training and supervision in the use of these measures.  
 
 
Statistical Analysis  
Data were analysed using SPSS Version 21. Bivariate Pearson correlation matrices 
were produced to examine associations between variables. A series of pre-specified 
hierarchical linear regressions were conducted using each domain of treatment 
decision-making capacity as a criterion variable. For each of the three treatment 
decision making capacity domains, understanding, appreciation, and reasoning three 
separate regression models were created. Using the forced entry method, predictor 
variables that had been shown to be associated with treatment decision-making 
capacity were entered in one block, then the hypothesised additional predictors of the 
jumping to conclusions bias and total cognitive biases were entered to explore if 
these variables contributed to the variance in each domain. Consultation with a senior 
statistician at the University of Edinburgh confirmed the appropriateness of the 
statistical plan to test the hypothesised addition of cognitive bias predictor variables.  
89 
 
Post hoc exploratory analyses were also carried out to see if the relationship between 
the JTC bias and capacity was mediated by positive symptoms, and to test if the 
relationship between cognitive biases and capacity was mediated by emotional 
distress. Simple mediation analysis was carried out using the process recommended 
by Preacher and Hayes (2004, 2008) and Hayes (2013) using PROCESS macros in 
SPSS version 21. 
Service user involvement 
The proposed study and methodology was presented to a service user group to get 
feedback on the acceptability and relevance of the research question, and the 
feasibility of the research design. Feedback was given by a group of 11 service users 
with experience of psychosis. Suggestions including word changes to participant 
information sheets, offering breaks, and allowing participants to bring a friend or 
family member along to the interview. The study proposal was also presented at a 
Knowledge Exchange Event with audience members including professionals, 
researchers, and experts by experience.  
Changes to protocol 
Some changes were made to the pre-registered protocol during the course of the 
study, largely due to the challenges in recruiting from a largely rural Health Board. 
First, recruitment was extended to an urban area (NHS Lothian). Second, the sample 
size was recalculated and reduced. This was achieved by calculating power to detect 
a change in the R
2 
statistic, and by reducing the number of predictor variables. Using 
GPower (Erdfelder, Faul, & Buchner, 1996) it was calculated that a sample of 25 
participants would have 80% power to detect large effects. Third, additional data was 
collected at baseline from 8 participants taking part in a parallel experimental study, 
which was administering largely the same measures (Turner & Hutton, 2015). 
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Inclusion of this data meant that the insight item from the PANSS had to be used to 
measure insight instead of the BCIS. Although BCIS data for those who completed it 
are still reported below, scores on the PANSS insight item were used for the main 
regression analyses. Finally, a post hoc mediation analysis was also conducted in 
order to examine whether emotional distress may mediate the effects of cognitive 
biases on capacity, as might be predicted by cognitive models of psychosis (Garety et 
al., 2001; Morrison, 2001). Although post hoc analyses are at risk of various forms of 
bias (eg hypothesising after the results are known; Kerr, 1998; John et al., 2012), 
they are regarded as acceptable if they are clearly labelled as post hoc and if they are 
treated correctly as being exploratory and suggestive rather than confirmatory or 






As shown in Figure 1, data from 25 participants was included in the analysis; data 
from 17 were collected by AL and  data from 8 were collected by DT (Turner & 
Hutton, 2015).  
 
As shown in Table 1, participants were largely male (84%) and were on average 
approximately 37 years old. Most had received a diagnosis of schizophrenia, with an 
average duration of illness of approximately 14-15 years ago. Participants were 
mildly to moderately ill on average, as evidenced by a mean PANSS total score of 71 
(Leucht et al., 2005). Just over one third evidenced the ‘jumping to conclusions’ 




Not meeting inclusion criteria: 2 
Withdrew: 4 
Administered measures for 
original study: 17 
Total number of participants 
included in analysis: 25 
Anonymised data from related 
study: 8 
Figure 1: Recruitment flowchart 
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decision-making style, as assessed by the Beads task, which is slightly lower than 
previous estimates (Dudley et al., 2015).  
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N = 25 
  
Participant characteristics Mean (SD), Median (Range) 
Age 37.63 (11.59), 37 (18 – 62) 
Years of education 11.6 (1.8), 12 (9 -14)  
Male gender, N (%) 21 (84%) 
Years since diagnosis 14.8 (12.2), 13 (0.5 – 41) 
Diagnosis  N (%) 
Schizophrenia, N (%) 19 (76%) 
Schizoaffective disorder N (%) 4 (16%) 
Psychotic episode N (%) 2 (8%)  
Descriptives  Mean (SD) / N (%) 
MacCAT-T Understanding  3.54 (1.49) 
MacCAT-T Appreciation 2.96 (1.06) 
MacCAT-T Reasoning 5.08 (2.50)  
PANSS Positive Symptoms 12.96 (5.09) 
PANSS Negative Symptoms 12.48 (4.00) 
PANSS Excited 8.00 (3.27) 
PANSS Depressed 8.60 (3.64)  
PANSS Cognition 7.56 (1.74)  
PANSS Insight 3.12 (2.81)  
PANSS Total  71.24 (20.50)  
BCIS Self Reflectiveness  14.00 (5.72)  
BCIS Self-Certainty 8.47 (5.17)  
BCIS Composite Insight 8.24 (7.29)  
JTC Draws to decision 5.84 (5.37)  
Evidencing JTC bias 9 (36%)  
CBQ-P Total 49.00 (13.06)  
CBQ-P Intentionalising  9.56 (2.72)  
CBQ-P Catastrophising  9.28 (3.01)  
CBQ-P Dichotomous Thinking  9.64 (2.83)  
CBQ-P JTC  11.36 (3.01)  
CBQ-P Emotional Reasoning  9.20 (2.94)  
RAS Total  163.29 (26.88)  
RAS Personal Confidence and Hope  34.94 (7.12)  
RAS Willingness to Ask for Help 12.29 (1.96)  
RAS Goal and Success Orientation 20.53 (3.78)  
RAS Reliance on Others 15.59 (3.10)  








Table 2 presents Pearson correlations between variables. Consistent with previous 
research, all MacCAT-T domains were significantly inversely associated with 
positive symptoms, cognition and insight, as measured by the PANSS. Large 
significant inverse correlations were also observed between each domain and the 
PANSS excitement factor, whereas negative symptoms were only significantly 
inversely correlated with MacCAT-T understanding ratings. Appreciation and 
PANSS insight were very highly correlated (r = .83, p < 0.01), which may suggest a 
conceptual overlap between the two concepts. Also consistent with previous theory 
and research, the Cognitive Biases Questionnaire for Psychosis was significantly 
correlated with depression and positive symptoms as measured by the PANSS, as 
well as cognitive insight as measured by the BCIS. Average draws to decision on the 
Beads task was also correlated with the PANSS Excitement factor, as well as overall 
cognitive biases (as measured by the CBQ-P total score). 
Consistent with the study hypothesis, understanding was positively correlated with 
average draws to decision on the Beads task. Contrary to the hypothesis, however, no 
significant correlations between MacCAT-T subscales and any other measures of 
cognitive biases, cognitive insight or subjective recovery were observed. In 
interpreting these findings, it should be noted that the sample of 25 had 80% power 
to detect only moderate to large correlations (r=0.40 or above). Also, given the early 
stage of this research we are less concerned about false positive findings (i.e., Type 1 
error), and therefore no adjustment for multiple comparisons has been performed. 
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-.13 .48* -.25 -.17 -.09 .16 .05 
MacCAT-T 
Appreciation 






-.50* -.01 -.01 -.13 -.03 .33 .17 -.17 
MacCAT-T 
Reasoning 




-.46* -.02 .10 .01 -.14 .15 .16 -.30 
PANSS  
Positive 
   1.00 .44* .78** .31 .60** .66** .50* -.24 .11 .45 -.22 -.40 .14 
PANSS  
Negative 
    1.00 .49* .30 .26 .67** .34 -.16 .10 .36 -.08 -.29 -.23 
PANSS 
Excitement 
     1.00 .34 .69** .71** .35 -.43* .39 .13 -.05 -.21 -.02 
PANSS 
Depression 
      1.00 -.10 .14 .45* -.27 .06 -.14 .36 .31 -.38 
PANSS  
Insight 
       1.00 .68** .06 -.13 .44* .13 -.22 -.36 .09 
PANSS 
Cognition 
        1.00 .37 -.23 .39 .38 -.18 -.52* -.02 
CBQ-P  
Total 
         1.00 -.43* .12 .32 -.19 -.54* -.39 
JTC DTD 
 
          1.00 -
.58** 
.17 -.34 .07 .22 
JTC  
Category 
           1.00 -.13 .24 -.05 -.20 
BCIS Self 
Certainty 






             1.00 .66** -.20 
BCIS 
Composite 
              1.00 .06 
RAS 
 
              .06 1.00 
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Table 3 Summary of regression models  
 
Understanding Appreciation Reasoning 
 B SE B β B SE B β B SE B β 
          
Model 1          
Constant 6.30 .96  4.64 .44  9.14 1.59  
PANSS Positive 
Symptoms 
-.07 .07 -.22 -.02 .03 -.11 -.10 .12 -.20 
PANSS Negative 
Symptoms  
-.09 .10 -.23 -.04 .05 -.16 -.12 .16 -.19 
PANSS Insight  -.15 .24 -.18 -.58 .11 -.96** -.64 .40 -.45 
PANSS Cognition -.05 .19 -.10 .13 .09 .34 .09 .31 .10 
Model 2           
Constant 5.64 1.29  4.61 .55  8.12 2.06  
PANSS Positive 
Symptoms 
-.12 .09 -.41 -.00 .04 -.00 -.10 .15 -.19 
PANSS Negative 
Symptoms  
-.09 .10 -.25 -.03 .04 -.12 -.09 .16 -.14 
PANSS Insight  -.00 .29 -.00 -.65 .12 -1.06** -.66 .46 -.46 
PANSS Cognition -.05 .21 -.08 .08 .09 .21 -.08 .33 -.09 
JTC bias -.54 .70 -.18 .56 .30 .26# 1.33 1.11 .26 
CBQ-P Total  .02 .03 .21 -.00 .01 -.01 .03 .05 .15 
Model Summary Model 1 R
2
 = .34, Adjusted R
2
 = 
.20, p = .07 
Model 2 R
2 









 = .73, Adjusted R
2
 = 
.67, p = .00 
Model 2 R
2 









 = .36, Adjusted R
2
 = 
.23, p = .06 
Model 2 R
2 





= .07, p = .08 
 
    
**p < .01, # p = .08
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The relationship between cognitive biases, symptoms and capacity 
A series of hierarchical multiple regression models were used to test whether the JTC 
bias and cognitive biases contributed to the prediction of the domains of treatment 
decision-making capacity. A summary of these models is presented in Table 3.  
Assumptions of multiple regression analysis  
The data used in the analysis and the subsequent regression models were checked to 
ensure that the assumptions underlying the statistical test had been met. Normal 
distribution of errors, multi-collinearity, linear relationship between variables, and 
homoscedasticity were checked as recommended by Osborne and Waters (2002) and 
Williams, Grajales, & Kurkiewicz (2013). Inspection of histograms, normal P-P 
plots, and scatter plots as recommended by Fields (2005) revealed residuals that were 
normally distributed, and no evidence of heteroscedasticity. For the regression 
models the largest variance inflation factor (VIF) was 4.53, and the average across 
predictor variables was 2.6. Tolerance statistics ranged from .23 to .67. Menard 
(1995) suggests that tolerance values below .2 indicate a potential problem, and 
Bowerman & O’Connell (1990) suggest that a single VIF greater than 10 or an 
average VIF substantially greater than 1 indicates that the regression model may be 
biased.   
The initial model consisted of factors that had been previously found to be related to 
treatment decision making capacity; positive symptoms, negative symptoms, insight, 
and cognition. Predictor variables measuring cognitive biases were then added in the 
second model. A dummy variable categorising participants into evidencing or not 
evidencing the JTC bias and the total score on the CBQ-P were added. The initial 
model accounted for 34%, 73%, and 36% of the variance in the understanding, 
appreciation, and reasoning domains respectively. This model reached statistical 
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significance for appreciation only, (p < .01). The change in R
2
 following the addition 
of the cognitive bias variables was small, ∆R
2
 = .04, .05, and .07 for understanding, 
appreciation, and reasoning respectively.  
The standardised beta co-efficient for the JTC bias in the model predicting each 
domain was large however, and approached statistical significance in the model of 
the appreciation domain (B = .563, p = .08). The inclusion of cognitive biases in 
Model 2 of appreciation reduced the predictive power of positive symptoms variable, 
although this did not increase the predictive power of the model. In the appreciation 
domain the largest predictors of the variance were insight, the JTC bias, and 
cognition. Consistent with the study hypothesis, this suggests that cognitive biases, 
and the JTC bias in particular, are related to treatment decision-making capacity, but 
the effect of cognitive biases may be through the expression of other variables, such 
as symptoms and emotional distress, as might be predicted by cognitive models of 
psychosis (Garety et al., 200l; Morrison, 2001).  
 
The partial and zero-order correlations of the models were examined to determine if 
variables were producing a suppression effect (Cohen & Cohen, 1983). For the 
reasoning and appreciation models the zero-order correlations between the criterion 
variables and JTC category were close to zero and partial correlations were larger 
than the zero-order correlations. These correlations are presented in Table 4. This 
indicates a suppression effect as defined by Velicer (1968), which occurs when the 
variance in one predictor variable is reduced by the addition of another variable. An 
independent variable that contributes little or no variance to the dependent variable 
may have a large non-zero beta weight because it purifies one or more independent 
variables of their irrelevant variance, thereby allowing it or their predictive power to 
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increase (Capraro & Capraro, 2001). This variable shares no variance directly with 
the dependent variable and thus contributes to the regression equation through 
removing irrelevant variance from other independent variables. The results of the 
multiple regression indicate that cognitive biases may act as a suppressor variable for 
the appreciation and reasoning domains of capacity.  
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Table 4: Zero-order and partial correlations 















-.49 -.29 -.53 -.00 -.49 -.15 
PANSS Negative 
Symptoms  
-.44 -.21 -.23 -.17 -.33 -.12 
PANSS Insight  -.44 -.00 -.83 -.78 -.55 -.32 
PANSS Cognition -.52 -.05 -.50 .21 -.46 -.06 
JTC bias -.25 -.18 -.13 .41 .01 .27 
CBQ-P Total  -.13 .20 -.01 -.02 -.02 .15 
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Suppression can occur in the case of an inconsistent mediation relationship between 
variables (MacKinnon, Krull, & Lockwood, 2000). An exploratory mediation 
analysis was conducted with positive symptoms as a mediating variable between 
jumping to conclusions and the domains of capacity to test for this mediating 
relationship. This analysis was post hoc and exploratory, and it should be noted that 
the sample in the current study did not have enough power to detect even large 
effects. According to the sample size calculations provided by Fritz and MacKinnon 
(2007) a sample seize of at least 36 would have been required.  
The results of the analysis are presented in Figures 2, 3, and 4 below. Results 
indicated that draws to decision had an inverse, but non-significant relationship with 
positive symptoms (b = -.23, SE = .19, p = .24) in all models.  
Positive symptoms had an inverse and significant relationship with understanding (b 
= -.12, SE = .05, p = 0.03). There was a direct effect of draws to decision on the 
understanding domain (b = .11, SE = .05, p = .04). The total effect of draws to 
decision on understanding was significant (b =.13, SE = .05, p = .02). Bootstrapping 
was used to test the indirect effect of draws to decision on Understanding and this 
was significant (95% CI 0.00, .08).  
Positive symptoms had an inverse and significant relationship with the appreciation 
domain (b = -.12, SE = .04, p = .01). There was an inverse relationship for the direct 
effect of draws to decision on the appreciation domain (b = -.03, SE = .04, p = .43). 
There was no total effect for draws to decision on appreciation (b=.00, SE =.04, p 
=.97). Positive symptoms had an inverse and significant relationship with the 
reasoning domain (b = -.24, SE = .09, p = .02). There was an inverse relationship for 
the direct effect of draws to decision on the reasoning domain (b = -.01, SE = .09, p = 
.92). The total effect for draws to decision on reasoning (b=.05, SE =.10, p =.63).  
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This exploratory mediation model indicates that the jumping to conclusions bias has 
both a direct and indirect effect on understanding through the mediating relationship 
with positive symptoms, such that the more draws to decision the lower the severity 
of positive symptoms, and the higher the severity of positive symptoms the lower the 
scores on understanding. Requiring more draws to decision also has a direct effect on 
capacity, such that more draws to decision, indicating that the person does not 
evidence the jumping to conclusions bias, indicate higher levels of understanding. 
This mediating relationship was not found in the other domains of treatment decision 
making capacity, appreciation and reasoning.  
The small sample size and exploratory nature of the mediation analysis limits our 
ability to draw conclusions or imply causality; however, these results are in line with 
the results of the regression model, and lend some initial support for the theoretical 
cognitive model of psychosis being able to predict variance in treatment decision-
making capacity in psychosis, particularly the understanding domain.  
 





JTC Draws to 
Decision 
b = -0.12 
a = -0.23 
c’ = 0.11 
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Figure 3: Exploratory mediation model – reasoning  
 
 











JTC Draws to 
Decision 
b = -0.24 a = -0.23 
c’ = -.01 
b = -0.12 
c’=-0.03 
a = -0.23 
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The relationship between capacity and subjective recovery 
Contrary to the hypothesis, no correlation between Recovery Assessment Scale 
(RAS) total scores and domains of decisional capacity were found (see Table 2). 
However, a correlation matrix was also computed to assess the relationship between 
the RAS subscales and the three domains of the MacArthur Competence Assessment 
Tool for Treatment, understanding, appreciation, and reasoning. Although no 
significant correlations were observed, it is notable that a number of were moderate 
to large in magnitude and suggestive of a trend towards greater capacity being 
associated with reduced recovery. For example, reasoning appears to have a large 
inverse albeit non-significant relationship with goal and success orientation. These 
results are presented in Table 5.  
 








    
RAS Total .05 -.17 -.30 
RAS Personal 
Confidence and Hope 
.12 -.08 -.17 
RAS Willingness to Ask 
for Help 
-.16 -.15 -.35 
RAS Goal and Success 
Orientation 
-.13 -.30 -.44 
RAS Reliance on Others .13 .10 -.19 
RAS No Domination by 
Symptoms 
.16 -.23 .13 
    




The relationship between cognitive biases, emotional distress and capacity: Post 
hoc analysis 
A post hoc exploratory mediation analysis was conducted to further explore the 
relationship between cognitive biases and capacity. Our aim was to explore whether, 
as predicted by cognitive models of psychosis (Garety et al., 2001), cognitive biases 
might have an indirect effect on capacity via their effect on emotional distress. 
Simple mediation analyses were conducted, with cognitive biases as measured by the 
CBQ-P as the independent variable, domains of capacity as the independent variable, 
and emotional distress as the mediating variable. A variable for emotional distress 
was calculated using the pentagonal model of the PANSS (White et al., 1997). An 
example model of the mediation analysis is depicted in Figure 3.  
Results indicated that although cognitive biases were a significant predictor of 
emotional distress (b = .23, SE = .08, p = .01), emotional distress did not predict 
scores on the understanding domain of the MacCAT-T (b = -.03, SE = .06, p = .61), 
the appreciation domain (b = .03, SE = .04, p = .55), or the reasoning domain (b = -
.05, SE = .10, p = .65).  
There was also no direct effect of cognitive biases on the understanding domain (b = 
-.01, SE = .03, p = .80), appreciation domain (b = -.01, SE= .02, p = -72), or 








Figure 5: Exploratory mediation model 2 – understanding  
 
 















a = 0.23 b = -0.03 
c’ = -0.01 
a = 0.23 b = -0.05 
c’ = 0.01 
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a = 0.23 b = -0.01 




Overall, the results of the regression analyses suggest that while cognitive biases and 
the 'jumping to conclusions’ bias may be associated with each of the treatment 
decision making capacity domains after variance attributable to symptoms, cognition 
and insight are accounted for, they do not improve the predictive power of the model. 
In the appreciation and reasoning models, the reduction in predictive power of 
positive symptoms following the addition of cognitive biases suggests that the 
hypothesised psychological variables of cognitive biases explain some of the 
variance in the predictors that had previously been shown to be related to 
appreciation, i.e. symptoms, cognition, and insight. However, the presence of a 
possible suppression effect indicates that this relationship may be more complex than 
the hypothesised relationships tested in the current study. Future research should aim 
to test these variables being partial mediators of the effect of cognitive biases on 
capacity, or to use structural equation modelling or path analysis with a larger sample 
to allow for more complex models of these relationships to be tested.  
There was no evidence from this study that recovery as defined by service users with 
psychosis is positively associated with current conceptualisations of decision-making 
capacity. Although underpowered, the direction of effect supported the opposite 
hypothesis; that greater capacity is associated with reduced recovery. Cognitive 
models of delusions and hallucinations focus on affective processes as well as 
cognitive processes in understanding psychosis and related distress (Freeman & 
Garety, 2003; Freeman et al., 2012). As would be predicted by this theory, cognitive 
biases were related to emotional distress in the mediation analysis. However we 





Clinical and theoretical implications 
This study presents preliminary evidence that cognitive biases may contribute to the 
variance observed in treatment decision-making capacity in psychosis – either 
directly or indirectly via their well-established relationship with psychotic 
experiences (Garety et al., 2013). This study also suggests that psychological 
variables such as cognitive biases may have different effects on each of the domains 
of capacity. To the best of the authors’ knowledge, this is the first study that has 
examined the relationship between these variables. Given previous research has 
shown that psychological therapy, such as metacognitive training (MCT), can change 
these cognitive biases (Eichner & Berna, 2016), this raises the possibility that 
capacity, and particularly understanding, may also be modifiable with this approach. 
Consistent with this, a small study by Naughton et al. (2012) found that MCT was 
associated with changes in participants’ scores on a measure of capacity.  However 
symptoms did not improve in this study, which may suggest that MCT had an effect 
on capacity via some related yet distinct mechanism. Koren et al (2005), for 
example, found that metacognitive awareness of cognitive processing was linked to 
improved decision-making capacity in people with psychosis, and it may be that 
MCT led to improvements in this domain. Much more research is required to fully 
understand the relationship between cognitive biases, thinking styles and treatment-
decision making capacity in psychosis. As discussed in a recent meta-analysis (van 
Oosterhout et al., 2016) psychological therapies for psychosis have moved from 
being predominantly content-oriented and focused on symptoms, to being process-
oriented and focus on distress (Garety et al. 2001; Morrison, 2001; Bentall et al. 
2009; Bennett & Corcoran, 2010). Research on variables contributing to treatment-
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decision making capacity may benefit from a similar process-oriented focus. 
Longitudinal studies, experimental studies and randomised controlled trials will be 
required to fully investigate whether such psychological processes have a causal 
effect on treatment decisional capacity.  
Research on service users’ conceptualisations of recovery has found that autonomy 
and empowerment are highly important factors (Law & Morrison, 2014). With this in 
mind, the high proportion of inverse correlations between participants’ recovery and 
the domains of the MacCAT-T in the current study, albeit non-significant, may point 
to a problem with the conceptualisation of capacity as it is currently defined. More 
research is required, but this raises the possibility that trying to improve capacity by 
trying to promote insight may be associated with adverse effects. If adequately 
powered studies find such a relationship, there could be significant implications for 
the existing conceptualisation of capacity, and the design of interventions focused on 
restoring it. It is also relevant to consider here the recent findings of Capdevielle et al 
2009 and Raffard et al 2014, who reported that anxiety was increased in those who 
had better scores on both appreciation and reasoning. This may not be entirely 
unexpected if treatment decision-making capacity, as conceptualised in the 
MacCAT-T, is in fact largely a re-expression of judgements of insight  -  as might be 
indicated by the high correlation between appreciation and PANSS insight scores 
observed in the current study. It is well established that insight is linked to greater 
emotional distress in psychosis, perhaps because of the stigma attached to this 
condition (Murri et al., 2016). If a person agrees they have psychosis it may result in 
a judgement of improved treatment decision-making capacity by their clinician, but 
the cost may be an increase in emotional distress. A psychological conceptualisation 
of capacity that is not wedded to a particular diagnostic framework may be better 
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placed to accommodate the differing narratives that many service users have, and 
may demand less compliance with dominant psychiatric narratives than current 
conceptualisations. For a fuller discussion of the problems of basing judgements of 
capacity on insight, see Allen (2009). 
 
If we take seriously the hypothesis that capacity, as currently defined, may be 
associated with reduced recovery, then the results of the exploratory mediation 
analysis, that emotional distress did not mediate a relationship between cognitive 
biases and capacity begins to make more sense. According to Law and Morrison’s 
(2014) survey of service users with psychosis, there is a consensus that recovery 
involves being able to cope well with mental or emotional problems. If recovery is 
inversely associated with capacity – or simply unrelated - then the same may be true 
for emotional distress and capacity. Further research, with larger samples than the 
current study, will be required to test these emerging hypotheses. 
 
It should be noted that the interview schedule for the MacCAT-T offered participants 
a choice between a hypothetical medication and no treatment. This approach does not 
assess capacity for other choices participants may have made, for example, whether 
to participate in psychological therapy. This is important because the majority of the 
participants interviewed for this study referred to coercive and seemingly traumatic 
previous experiences with medication and choice, and this may have affected their 
reasoning. This echoes the findings of Stovell and colleagues (2016), and suggests 
future research on treatment decision-making capacity in psychosis should aim to 
investigate how previous treatment decision-making experiences within the mental 
health care system may affect their current choices. Whether individuals who lack 
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capacity to make decisions about medication may also retain the capacity to make 
decisions about other treatments is also an important question for future research.  
 
Strengths and limitations  
The involvement of service users in the conception and design of this study, as 
recommended by the British Psychological Society (2004), is a particular strength. 
This ensured the question was meaningful to service users, and that the design was 
not overly burdensome. The use of a structured assessment of treatment decision-
making capacity is also a strength. The MacCAT-T is the most frequently used 
instrument to assess treatment-decision making capacity (Cairns et al., 2005), 
meaning the findings of this study are directly comparable to those produced by other 
groups. On the other hand, this measure does seem to conflate compliance with an 
illness model with capacity, and leaves little room for either recovery-focused (Law 
& Morrison, 2014), emancipatory (Romme & Escher, 1989) or psychological 
explanations of experiences such as hearing voices (Garety et al., 2001; Morrison, 
2001). Adaptations of this measure to accommodate these legitimate perspectives 
may be required. 
 
The small sample size in this study limits our ability to draw conclusions from the 
data. The study had 25 participants for the regression analysis. An analysis of power 
conducted using G*Power V 3.1 (Erdfelder, Faul, & Buchner, 1996), indicates that a 
sample of 25 participants, as achieved by the current study, had nearly 70% power (1 
– α error probability) to detect large effect sizes in a test of R
2
 change. However, a 
larger sample size would have allowed for the detection of smaller effect sizes, and 
allowed for adequate power to test for possible interaction effects. In addition, the 
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sample recruited was largely male; although some studies have found that a greater 
proportion of people with psychosis are male (Ochoa et al., 2012); this may still have 
had an impact on the generalisability of the results.  
 
The use of hypothetical decisions about medication to assess treatment decision 
making capacity, as required by the MacCAT-T, may limit the ecological validity of 
the results. Recruiting participants who are currently making a treatment decision 
may mitigate this, and may increase the emotional salience of the decision. Previous 
studies have recruited participants on their admission to hospital to assess their 
capacity to make these very real decisions (Owen et al., 2009; 2011). Indeed, the 
MacCAT-T is not often used in clinical practice and so caution is needed before 
generalising the findings to assessments of capacity that are routinely carried out in 
clinical practice.  
 
The measure of cognitive impairment in this study was calculated using the five 
factor model of the PANSS (Rodriguez-Jiminez et al., 2013). While this five factor 
structure has been validated, future research may benefit from using more direct 
measures of cognitive performance. Finally, the insight item of the PANSS was used 
in the regression analysis as a proxy measure of insight and awareness of disorder, 
however future research would benefit from using measures that are based on a 
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Appendix A Search Strategy  
The databases Embase, Embase Classic, Medline, and PsycInfo were searched for 
papers published between 1947 and October 2015.  
The terms (Schizo* OR Psychosis) AND (Capacity OR Decision making OR 
Consent) AND  (Treatment OR Health care) were entered into these databases. 
Results were limited to English language studies and human subjects. Duplicates 
were removed through placing a limiter on the search.  
Studies that were included after full text review were hand searched for relevant 
studies.  
All corresponding authors of included studies were contacted by email to identify 
any unpublished studies, or extra studies that had not been identified by database 
























Appendix B Adapted risk of bias tool  
We adapted a tool for assessing the methodological quality of observational studies 
that has been successfully employed in prior research undertaken by the Agency for 
Healthcare Research and Quality (AHRQ). The main methodological quality criteria 
were retained but the underlying factors related to each study quality criterion were 
adapted in some instances for this specific context. Each study is assessed on a 
number of methodological quality criteria (for example, unbiased selection of 
groups, sample-size calculations, and so on) that are rated as being met, not met, 
partially met, or being unclear. 
General instructions: Grade each criterion as ‘Yes’, ‘No’, ‘Partially’, or ‘Can’t tell’. 
Factors to consider when making an assessment are listed under each criterion. 
Where appropriate (particularly when assigning a ‘No’, ‘Partially’, or ‘Can’t tell’ 
score), please provide a brief rationale for your decision (in parentheses) in the 
evidence table. 
1. Unbiased selection of the cohort? 
Factors that help reduce selection bias: 
○ Inclusion/exclusion criteria: 
○ Recruitment strategy 
▪  Clearly described. 
▪  Relatively free from bias (selection bias might be introduced, for example, by 
recruitment via advertisement). 
 
2. Selection minimizes baseline differences in prognostic factors? 
Factors to consider: 
○ Was selection of the comparison group appropriate? 
○ Is the comparison group matched with the clinical group on key demographics 
(that is age and gender)? 
 
3. Sample size calculated? 
Factors to consider: 
○ Did the authors report conducting a power analysis or describe some other basis 
for determining the adequacy of study group sizes for the primary outcome(s) of 
interest to us? 
○ Where a power calculation is presented, do the final numbers obtained match up to 
this (for example, within 10% of required numbers)? 
 
4. Adequate description of the cohort? 




○ Diagnosis/clinical status 
 
5. Validated measure of treatment decision making capacity or of domains of 
treatment decision making capacity? 
Factors to consider: 
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○ Was the method used to assess treatment decision making capacity clearly 
described (details should be sufficient to permit replication in new studies)? 
○ Was a valid and reliable measure used to assess treatment decision making 
capacity (subjective measures based on self-report tend to have lower reliability and 
validity than objective measures such as clinical interview)?  
 
6. Validated measures for assessing associated factors of interest? 
Factors to consider: 
○ Where possible studies should use validated measures to assess factors, for 
example a validated measure of depression rather than a subjective rating of mood.  
○ Were these measures implemented consistently across all study participants? 
 
7. Outcome assessment blind to exposure? 
Factors to consider: 
○ Were the study investigators who assessed outcomes blind to whether participants 
had impaired treatment decision making capacity and vice versa?  
 
 
8. Analysis controls for confounding? 
Factors to consider for controlled studies: 
○ If groups were not matched as baseline, did the analysis control for any baseline 
differences between groups? 
○ Does the study identify and control for important confounding variables and effect 
modifiers (for example, IQ)? 
 
9. Analytic methods appropriate? 
 
Factors to consider: 
○ Was the kind of analysis done appropriate for the kind of outcome data 
(categorical, continuous, and so on)? 
○ Was the number of variables used in the analysis appropriate for the sample size 
(the statistical techniques used must be appropriate to the data and take into account 
issues such as controlling for small sample size, clustering, rare outcomes, multiple 
comparison, and number of covariates for a given sample size)? 
 
For intervention studies the following additional criteria were rated:  
 
10. Adherence to intervention?  
Factors to consider:  
 Was the intervention manualised?  
 Did all participants receive the same number of sessions / intensity of 
intervention?  
 
11. Adequate follow-up period?  
Treatment decision making capacity is time and decision specific. As such it is 
expected to change over time. To ensure that the change in capacity can be 
attributable to the intervention studied, a short follow up period is more valid than a 
longer follow up period.  
 
Factors to consider:  
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 How long was the follow up period? Maximum follow up period – 2 weeks 
 
 
12. Completeness of follow up?  
Factors to consider:  
 Did attrition from any group exceed 30%? (Attrition is measured in relation 
to the time between baseline/allocation and outcome measurement. Where 
different numbers of patients are followed up for different outcomes, use the 
number followed up for the primary outcome for this calculation.) 






























Risk of bias Interpretation Within a study Across studies 
Low risk of bias Plausible bias unlikely to seriously alter the 
results. 
Low risk of bias for all key domains. Most information is from studies at low 
risk of bias. 
Unclear risk of bias Plausible bias that raises some doubt 
about the results 
Unclear risk of bias for one or more key 
domains. 
Most information is from studies at low or 
unclear risk of bias. 
High risk of bias Plausible bias that seriously weakens 
confidence in the results. 
High risk of bias for one or more key 
domains. 
The proportion of information from studies 
at high risk of bias is sufficient to affect the 
interpretation of the results. 
 
Appendix C Cochrane Risk of Bias tool for Randomised Controlled Studies 
 
 
Domain Description Review authors’ judgement 
Sequence generation Describe the method used to generate the allocation sequence in sufficient 
detail to allow an assessment of whether it should produce comparable 
groups. 
Was the allocation 
sequence adequately 
generated? 
Allocation concealment Describe the method used to conceal the allocation sequence in sufficient 
detail to determine whether intervention allocations could have been foreseen 
in advance of, or during, enrolment. 
Was allocation 
adequately concealed? 
Blinding of participants, 
personnel and outcome assessors 
Assessments should be made for 
each main outcome (or class of 
outcomes) 
Describe all measures used, if any, to blind study participants and personnel 
from knowledge of which intervention a participant received. Provide any 
information relating to whether the intended blinding was effective. 
Was knowledge of the 
allocated intervention 
adequately prevented 
during the study? 
Incomplete outcome data 
Assessments should be made for 
each main outcome (or class of 
outcomes) 
Describe the completeness of outcome data for each main outcome, including 
attrition and exclusions from the analysis. State whether attrition and exclusions 
were 
reported, the numbers in each intervention group (compared with total 
randomized participants), reasons for attrition/exclusions where reported, and 
any re-inclusions in analyses performed by the review authors. 
Were incomplete outcome 
data adequately addressed? 
Selective outcome reporting State how the possibility of selective outcome reporting was examined by the 
review authors, and what was found. 
Are reports of the study free 
of suggestion of selective 
outcome reporting? 
Other sources of bias State any important concerns about bias not addressed in the other domains 
in the tool. 
If particular questions/entries were pre-specified in the review’s protocol, 
responses should be provided for each question/entry. 
Was the study apparently 
free of other problems that 




Possible approach for summary assessments outcome (across domains) within and across studies
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Criteria for judging risk of bias in the ‘Risk of bias’ assessment tool 
 
SEQUENCE GENERATION 
Was the allocation sequence adequately generated? [Short form: Adequate sequence generation?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
The investigators describe a random component in the sequence generation process such as: 
  Referring to a random number table; Using a computer random number generator; Coin tossing; Shuffling 
cards or envelopes; Throwing dice; Drawing of lots; Minimization*. 
*Minimization may be implemented without a random element, and this is considered to be equivalent to being random. 
Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
The investigators describe a non-random component in the sequence generation process. Usually, the description would 
involve some systematic, non-random approach, for example: 
      Sequence generated by odd or even date of birth; 
      Sequence generated by some rule based on date (or day) of admission; 
      Sequence generated by some rule based on hospital or clinic record number. 
Other non-random approaches happen much less frequently than the systematic approaches mentioned above and 
tend to be obvious.  They usually involve judgement or some method of non-random categorization of participants, 
for example: 
      Allocation by judgement of the clinician; 
      Allocation by preference of the participant; 
      Allocation based on the results of a laboratory test or a series of tests; 
      Allocation by availability of the intervention. Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
Insufficient information about the sequence generation process to permit judgement of ‘Yes’ or ‘No’. 
ALLOCATION CONCEALMENT 
Was allocation adequately concealed? [Short form: Allocation concealment?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an 
equivalent method, was used to conceal allocation: 
      Central allocation (including telephone, web-based, and pharmacy-controlled, randomization); 
      Sequentially numbered drug containers of identical appearance; 
      Sequentially numbered, opaque, sealed envelopes. 
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Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, 
such as allocation based on: 
      Using an open random allocation schedule (e.g. a list of random numbers); 
  Assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-
opaque or not sequentially numbered); 
      Alternation or rotation; 
      Date of birth; 
      Case record number; 




Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
Insufficient information to permit judgement of ‘Yes’ or ‘No’. This is usually the case if the method of concealment is 
not described or not described in sufficient detail to allow a definite judgement – for example if the use of assignment 
envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed. 
BLINDING OF PARTICIPANTS, PERSONNEL AND OUTCOME ASSESSORS 
Was knowledge of the allocated interventions adequately prevented during the study? [Short form: Blinding?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
Any one of the following: 
  No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be 
influenced by lack of blinding; 
      Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken; 
  Either participants or some key study personnel were not blinded, but outcome assessment was blinded and 
the non- blinding of others unlikely to introduce bias. 
Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
Any one of the following: 
  No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by 
lack of blinding; 
      Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken; 
      Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce 
bias. 
Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
Any one of the following: 
      Insufficient information to permit judgement of ‘Yes’ or ‘No’; 
      The study did not address this outcome. 
INCOMPLETE OUTCOME DATA 
Were incomplete outcome data adequately addressed? [Short form: Incomplete outcome data addressed?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
Any one of the following: 
      No missing outcome data; 
  Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring 
unlikely to be introducing bias); 
      Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across 
groups; 
  For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough 
to have a clinically relevant impact on the intervention effect estimate; 
      For continuous outcome data, plausible effect size (difference in means or standardized difference in means) among 
missing 
outcomes not enough to have a clinically relevant impact on observed effect size; 
      Missing data have been imputed using appropriate methods. 
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Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
Any one of the following: 
  Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or 
reasons for missing data across intervention groups; 
  For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to 
induce clinically relevant bias in intervention effect estimate; 
      For continuous outcome data, plausible effect size (difference in means or standardized difference in means) among 
missing 
outcomes enough to induce clinically relevant bias in observed effect size; 
      ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at 
randomization; 




Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
Any one of the following: 
  Insufficient reporting of attrition/exclusions to permit judgement of ‘Yes’ or ‘No’ (e.g. number randomized not 
stated, no reasons for missing data provided); 
      The study did not address this outcome. 
SELECTIVE OUTCOME REPORTING 
Are reports of the study free of suggestion of selective outcome reporting? [Short form: Free of selective reporting?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
Any of the following: 
  The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of 
interest in the review have been reported in the pre-specified way; 
  The study protocol is not available but it is clear that the published reports include all expected outcomes, 
including those that were pre-specified (convincing text of this nature may be uncommon). 
Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
Any one of the following: 
      Not all of the study’s pre-specified primary outcomes have been reported; 
  One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. 
subscales) that were not pre-specified; 
      One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is 
provided, 
such as an unexpected adverse effect); 
      One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-
analysis; 
      The study report fails to include results for a key outcome that would be expected to have been reported for such a 
study. 
Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
Insufficient information to permit judgement of ‘Yes’ or ‘No’. It is likely that the majority of studies will fall into this 
category. 
OTHER POTENTIAL THREATS TO VALIDITY 
Was the study apparently free of other problems that could put it at a risk of bias? [Short form: Free of other bias?] 
Criteria for a judgement of 
‘YES’ (i.e. low risk of bias). 
The study appears to be free of other sources of bias. 
Criteria for the judgement of 
‘NO’ (i.e. high risk of bias). 
There is at least one important risk of bias. For example, the study: 
      Had a potential source of bias related to the specific study design used; or 
      Stopped early due to some data-dependent process (including a formal-stopping rule); or 
      Had extreme baseline imbalance; or 
      Has been claimed to have been fraudulent; or 
      Had some other problem. 
Criteria for the judgement of 
‘UNCLEAR’ (uncertain risk of 
bias). 
There may be a risk of bias, but there is either: 
      Insufficient information to assess whether an important risk of bias exists; or 
      Insufficient rationale or evidence that an identified problem will introduce bias. 
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Appendix D GRADE Assessment of Quality  
Outcomes where more than one study contributed evidence were assessed for overall 
quality using the GRADE approach. The rating of quality was conducted by the first 
author, and discussed with second author PH. The following criteria for downgrading 
were applied to each outcome.  
Criteria for downgrading  
Study limitations  
Individual studies were rated for risk of bias using a tool adapted from Williams et 
al. (2010). We downgraded by 1 point if three of the parameters in our risk of bias 
assessment had ≥50% studies with at least one ‘no’ or ‘unclear’ rating, and 2 points if 
four or more parameters had ≥50% studies with ratings of ‘no or unclear’.  
Imprecision 
Imprecision was judged by examining the 95% CI of the effect sizes for the outcome 
of interest across studies. Optimal sample size was calculated for outcomes, we 
downgraded 1 point for imprecision when optimal sample size had not been reached, 
or when 95% CI contained 0.  
Inconsistency  
For outcomes included in meta-analysis where the I
2
statistic was calculated we 
downgraded by 1 point for inconsistency if the I
2
 statistic was ≥40% in the context of 
an unclear direction of effect or ≥75% in the context of a clear direction of effect. We 
downgraded by 2 points if the I
2
 statistic was ≥75% in the context of an unclear 
direction of effect. 
For outcomes included in the narrative review, we downgraded for inconsistency in 
cases where 95% CI did not overlap, and heterogeneity could not be explained. We 
downgraded by 1 point in this case.  
Indirectness 
The review was exploratory in nature, therefore outcomes had not been pre-specified. 
However, for outcomes that had used significantly different measures of the same 
construct, we downgraded by 1 point for indirectness.  
Rating up the quality of evidence 
In the context of a large effect size, we upgraded by 1 point where the effect size 
calculated was consistently large. Using Cohen’s (1988; 1992) criteria, an effect size 







Excluded studies with reasons  
Ackerman et al. (2015) Case description  
Ang et al. (2009)  Case description 
Baklar (1998)  Editorial  
Bingham (2012)  Case description 
Bitter et al. (2015)  No measure of capacity 
Bowen & Barnes (1994)  No measure of capacity 
Bunn et al. (1997)  No measure of capacity 
Bursztajn et al. (1991)  Case description 
Burton & Twamley (2015)  No measure of capacity 
Dudzinski & Sullivan (2004)  Case description 
Falzer & Garman (2012)  No measure of capacity 
Gray & O’Reilly (2009)  Case description 
Grimes et al. (2000) No measure of capacity 
Grisso & Appelbaum (1995)  Comparison of legal standards. No 
measure of capacity.  
Grisso & Appelbaum (1995) (2)  Brief report – no usable data 
Hamann et al. (2011)  No measure of capacity 
Irwin, Knight, & Pirl (2014)  No measure of capacity 
Jacob et al. (2005)  Wrong population 
Jeste, Depp, & Palmer (2006)  Review paper 
Karel et al. (2010)  Sample <60% psychosis or schizophrenia 
Krogsgaard Bording, Munk-Jorgensen, 
& Puschner (2012)  
 
No measure of capacity 
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Lee et al. (2010)  No measure of capacity 
Linden & Chaskel (1991)  No measure of capacity 
Mahone (2004)  No measure of capacity 
Mandarelli et al. (2014)  Did not examine relationship between 
factors and capacity 
Maxmin et al. (2009)  Sample <50% psychosis or schizophrenia  
McSherry & Bruckard (2009)  Editorial 
Meszaros et al. (2011)  No measure of capacity 
Moye et al. (2008)  Did not examine relationship between 
factors and capacity 
Parsons & Kennedy (2007) No measure of capacity 
Paul & Oyebode (1999)  Did not examine relationship between 
factors and capacity 
Roth et al. (1982)  Sample <50% psychosis or schizophrenia 
Schlecter (2008)  Case description 
Seeman (2014)  Case description 
Shek, Lyons, & Taylor (2010)  Used SIDMA rather than capacity 
Vollman et al. (2003)  Did not examine relationship between 
factors and capacity 
Weinstock, Copelan, & Bagheri (1984)  Did not examine relationship between 
factors and capacity 
Wirshing et al. (1998) Research decision making capacity rather 
than treatment decision making capacity 
Wirshing, Sergei, & Mintz (2005)  Research decision making capacity rather 
than treatment decision making capacity 
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Ms Amanda Larkin 
Trainee Clinical Psychologist 
NHS Dumfries and Galloway 
Department of Psychological Services and 
Research 
Cree West, Crichton Hall, 
Dumfries 
DG14TG 
West of Scotland REC 4 
Ground Floor, Tennent Building 
Western Infirmary 






Direct line 0141-211-1722 
Fax 0141-211-1847 
 e-mail Wosrec4@ggc.scot.nhs.uk 
 
 
Dear Ms Larkin 
 
Study title: Exploring the role of cognitive biases in treatment 
decision making capacity of people who have 
experienced psychosis 
REC reference: 15/WS/0001 
IRAS project ID: 149335 
 
The Research Ethics Committee reviewed the above application at the 
meeting held on 09 January 2015.   Thank you for attending to discuss the 
application. 
 
We plan to publish your research summary wording for the above study on the 
HRA website, together with your contact details. Publication will be no earlier 
than three months from the date of this favourable opinion letter.  The 
expectation is that this information will be published for all studies that receive 
an ethical opinion but should you wish to provide a substitute contact point, 
wish to make a request to defer, or require further information, please contact 
the REC Manager Ms Evelyn Jackson, wosrec4@ggc.scot.nhs.uk. Under very 
limited circumstances (e.g. for student research which has received an 
unfavourable opinion), it may be possible to grant an exemption to the 
publication of the study. 
 
1. Ethical opinion 
 
The members of the Committee present gave a favourable ethical 
opinion of the above research on the basis described in the application 
form, protocol and supporting documentation, subject to the conditions 
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specified below. . 
 
2. Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to 
the start of the study. 
 
1. In the Participant Information Sheet: 
(a) In section headed “What is the purpose of the study?”, the Committee 
suggested that the third sentence should be reworded – “…..not able to 
make decisions about their health care….”. 
(b) In section headed “What are the possible benefits of taking part?”, the first 
sentence should be removed. 
(c) In section headed ”What will happen to me if I take part?”, the Committee 
suggested that you clarify or remove “or somewhere else” from the sentence 
relating to where you would meet with the patient. 
(d) In section headed “Who is funding and organising this study?”, move reference 
to the research ethics committee to a new section headed “Who has reviewed 
this study?” and insert the correct name of the REC, i.e. West of Scotland 
Research Ethics Committee 4. 
 
2. The Committee asked that you uniformly use the term “thinking styles” 
throughout the paperwork that would be given to study participants. 
 
3. You should notify the REC in writing once all 
conditions have been met (except for site 
approvals from host organisations) and provide 
copies of any revised documentation with 
updated version numbers. The REC will 
acknowledge receipt and provide a final list of the 
approved documentation for the study, which can 
be made available to host organisations to 
facilitate their permission for the study. Failure to 
provide the final versions to the REC may cause 
delay in obtaining permissions. 
 
Management permission or approval must be obtained from each host 
organisation prior to the start of the study at the site concerned. 
 
Management permission (“R&D approval”) should be sought from all NHS 





Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites (“participant identification centre”), guidance 
should be sought from the R&D office on the information it requires to give permission 
for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with 
the procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) 
must be registered on a publically accessible database. This should be before 
the first participant is recruited but no later than 6 weeks after recruitment of the 
first participant. 
 
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment. We will audit the 
registration details as part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research 
is registered but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required 
timeframe, they should contact hra.studyregistration@nhs.net. The expectation 
is that all clinical trials will be registered, however, in exceptional circumstances 
non registration may be permissible with prior agreement from NRES. Guidance 
on where to register is provided on the HRA website. 
 
4. It is the responsibility of the sponsor to ensure 
that all the conditions are complied with before 
the start of the study or its initiation at a 
particular site (as applicable). 
 




The favourable opinion applies to all NHS sites taking part in the study taking 
part in the study, subject to management permission being obtained from the 
NHS/HSC R&D office prior to the start of the study (see “Conditions of the 
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favourable opinion” below). 
 
5. Summary of discussion at the meeting 
 
Other ethical issues were raised and resolved in preliminary discussion before your 
attendance at the meeting. 
 
Social or scientific value; scientific design and conduct of the study 
 
The Committee noted in the Feedback Sheet for Academic Work from University 
of Scotland, NHS Scotland, Clinical Psychology Training Programme, that there is 
reference to recruiting patients who do not have the capacity to consent. However, 
it was stated in the filter pages and in QA17-2 (exclusion criteria) of the IRAS REC 
application form that patients who are unable to consent to partake in research 
would not be recruited to the study. 
 
You confirmed that patients who were unable to consent to partake in research would 
not be recruited to the study. 
 
The Committee wondered if it was feasible to recruit 46 patients in the relatively 
short period of time reported. 
 
You explained that you were confident about being able to recruit sufficient numbers and 
that you had discussed this with Psychiatrists in NHS Dumfries and Galloway.  You also 
explained that should there be a problem recruiting sufficient participants, then you could 
approach Mental Health services in other Health Board areas. 
 
6. Recruitment arrangements and access to 
health information, and fair participant 
selection 
 
The Committee asked for more information as to who would assess a patient to 
determine if they had capacity to consent to take part in a study. 
 
You explained that key workers in Mental Health Care Teams would assess whether a 
patient would have the capacity to consent to take part in research and if yes, would ask 
the patient for permission for you to contact them about the study. When you had 
contacted the patient and given them the PIS, the patient would have up to a week to 
decide if they wished to take part. You further explained that if you had any doubts, 
following this initial contact, about a patient’s capacity to consent, then you would not 




7. Care and protection of research participants; 
respect for potential and enrolled 
participants’ welfare and dignity 
 
The Committee wondered if a two hour session would prove burdensome to 
participants. 
You explained that you had taken advice about the length of the session but that 
would gauge each individual patient and should this be the case, then the session 
could be split into two x one hour sessions. 
 
8. Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
Document Version Date 
Copies of advertisement materials for research participants 
[Referrer Poster] 
V2 25 November 2014 
Covering letter on headed paper   
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Certificate of Insurance] 
Version 1 08 August 2014 
GP/consultant information sheets or letters [GP letter] V2 25 November 2014 
Interview schedules or topic guides for participants [MacCAT-T 
Interview Guide] 
V1 26 November 2014 
Interview schedules or topic guides for participants [PANSS 
Interview Guide] 
V1 26 November 2014 
Participant consent form [Participant Consent Form] V2 20 November 2014 
Participant information sheet (PIS) [Participant Information Sheet] V2 20 November 2014 
REC Application Form [REC_Form_02122014]  02 December 2014 
Referee's report or other scientific critique report [Assessment from 
Academic Institution] 
Version 1 04 August 2014 
Research protocol or project proposal [Research Protocol] V2 20 November 2014 
Summary CV for Chief Investigator (CI) [CV Amanda Larkin (Chief 
Investigator) ] 
Version 1 17 October 2014 
Summary CV for supervisor (student research) [CV Paul Hutton 
(Academic Supervisor)] 
Version 1 17 October 2014 
Validated questionnaire [Beck Cognitive Insight Scale]   
Validated questionnaire [Cognitive bias questionnaire for psychosis]   
Validated questionnaire [Recovery Assessment Scale]   
 
9. Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are 
listed on the attached sheet. 
 






The attached document “After ethical review – guidance for researchers” 
gives detailed guidance on reporting requirements for studies with a 
favourable opinion, including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is 
updated in the light of changes in reporting requirements or procedures. 
 
11. User Feedback 
 
The Health Research Authority is continually striving to provide a high 
quality service to all applicants and sponsors. You are invited to give your 
view of the service you have received and the application procedure. If you 
wish to make your views known please use the feedback form available on 
the HRA website: http://www.hra.nhs.uk/about-the- hra/governance/quality-
assurance/ 
 
12. HRA Training 
 
We are pleased to welcome researchers and R&D staff at our training days 
– see details at http://www.hra.nhs.uk/hra-training/ 
 
 





for Dr Brian Neilly Chair 
 
Enclosures: List of names and professions of members who were present at the meeting 
“After ethical review – guidance for researchers” 
 
Copy to: Ms Jo-Anne Robertson 
Dr Gwen Baxter, R&D, NHS Dumfries and Galloway 







Attendance at Committee meeting on 09 


























Also in attendance: 
 
Name Position (or reason for attending) 
Dr Judith Godden Scientific Adviser 







Name Profession Present Notes 
Mr Gavin Bell Managing Intelligence 
Support Co-ordinator 
Yes  
Ms Cristina Coelho Senior Pharmacist 
Clinical Effectiveness 
Yes  
Dr Clair Evans Consultant Paediatric 
and Perinatal Pathologist 
Yes  
Dr Michael Fail Consultant Geriatrician Yes  
Dr Claire Fang GP No  
Dr Ken James Consultant Anaesthetist Yes  
Miss Fiona Mackelvie Retired Administrator Yes  
Mrs Karen McIntyre Account Manager, ICON 
plc 
Yes  
Dr Brian Neilly (Chair) Consultant Physician Yes  
Mrs Linda Renfrew Consultant 
Physiotherapist in MS 
Yes  
Dr  Subra Viswanathan Consultant GI 
Radiologist 
Yes  
Mr John Woods  Yes  










Study title: Exploring cognitive biases in the treatment decision making 
capacity of people who have experienced psychosis.  
We would like to ask you to take part in our research study. Before you 
decide we would like you to know why the research is being done and what it 
would mean for you.  
One of our team will meet with you to go through the information sheet with 
you and answer any questions you have. This should take about 10 – 15 
minutes.  
Talk to other people about the study if you want to. You can contact the 
research unit of NHS Dumfries and Galloway if you want to talk about the 
study with them. You can also contact Kaleidoscope, the Dumfries branch of 
Support in Mind Scotland. These people are not connected with this 
research, and can talk to you independently of the research team. 
 
What is the purpose of this study?  
Dumfries & Galloway 
  
Research & Development 
Support Unit 






Tel: 01387 241165 
 











We are doing this study to see if thinking styles (also known as cognitive 
biases) are linked to whether or not someone is able to make decisions about 
their health care. Thinking styles have been shown by other research to be 
involved in psychosis. People who have experienced psychosis are more 
likely to not be able to make decisions about their health care than other 
people. We want to see if thinking styles are linked to decision making ability. 
We will ask you about thinking styles, symptoms, and what you think about 
your disorder.  We also want to see if decision making ability is linked to 
recovery.  
Why are you asking me to take part? 
We have asked you to take part in the study because you are aged between 
18 and 65 years, because you have had psychosis, and because you have 
been told you have a psychotic disorder. 
Do I have to take part?  
No, you do not have to take part. It is up to you if you take part in this study. If 
you want we will meet with you to talk about the study. We will go through 
this information sheet. If you agree to take part we will then ask you to sign a 
form. This form says that you agree to take part. You can stop taking part at 
any time, without saying why. Taking part in this study will not affect your 
health care. 
What will happen to me if I take part?  
We will meet with you to ask some questions, and do a computer task. First 
we will talk to you about the study, and ask for your consent to take part. If 
we’re not sure that you understand the consent fully, we will talk to your key 
worker about it to make sure.  
After you give consent, we will ask you some questions about decision 
making, and some questions on symptoms and your experiences. You will 
then be asked to look at a computer screen and answer a question based on 
what’s on the computer screen.  
We should only need to meet with you once. It will take about two hours. You 
can take breaks when you like. We can meet you at a health centre, or at 
home. You can bring someone with you, if you like.  
If you want to take part, we will let your GP and health care team know.  
What will I have to do?  
If you want to take part, you will have to meet with us once. You will be asked 
to answer some questions, and look at a computer task. 
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What are the possible disadvantages and risks of taking part?  
We don’t think that there will be anything bad about taking part. You might 
get tired. If this happens, you can take a break. You might find some things 
hard to talk about. If this happens, you can take a break, or we can talk about 
what has come up for you. You might find it hard to come along to an 
interview. We will try to make it as easy as we can for you.  
What are the possible benefits of taking part?  
We want to know about your experiences and thoughts on things. You might 
not notice any benefit. We hope that this study will benefit people like you in 
the future. It will be good for doctors to know more about decision making 
ability. 
What will happen if I don’t want to carry on with the study?  
We will only need to meet with you once to carry out the study. If you decide 
that you don’t want to carry on, we will stop. If you decide after we have done 
the interview that you don’t want to take part, you can let us know. We will 
take your information out of the study. There will be no difference to the 
health care you receive if you don't want to continue with the study.  
Will people know what I say?  
Personal records will be kept in a locked filing cabinet in an NHS office. You 
name will not be put on any of the records that we collect. This means that no 
one will be able to tell that it came from you. Once we have finished the 
study, anything with your name on it will be shredded. Records without your 
name will then be stored on computers at the University of Edinburgh.  
What will happen to the results of the study?  
You will receive a copy of the results once the study has finished. The results 
will be published in a science journal, and they will be presented to service 
users and professionals. Your name will not appear anywhere in the results. 
The study will also be handed in to the University of Edinburgh to be marked.  
Who is funding and organising this study?  
The study is funded by the NHS and the University of Edinburgh. The West 
of Scotland Research Ethics Committee 4 has reviewed and approved this 
study.  
If I want to take part, what do I do next?  
If you want to take part, tell your keyworker. They will give us your details. 




The researcher, Amanda Larkin, will meet with you to go through the study 
details and get your consent to take part. You will have at least a week to 
think about the information on this sheet before we meet with you. You will be 
asked to sign a form to say that you want to take part, and to make sure that 
you know what the study involves. We will also let your GP know that you are 
taking part in the study.  
What if I’m not happy with what happens?  
You can drop out of the study at any time, by contacting us using the details 
below.  
If you have any more questions about the study you can ask Amanda 
Larkin 
TEL:  01387 244495 
EMAIL: amanda.larkin@nhs.net 
The full contact details for the people doing this research are:  
Chief Investigator  
Amanda Larkin,  
Trainee Clinical Psychologist,  
Department of Psychological Services and Research,  
Crichton Hall,  








Dr Paul Hutton,  
Chancellor’s Fellow and Clinical 
Psychologist,  
University of Edinburgh, 
School of Health in Social Science,  






Dr Katie Whyte,  
Clinical Psychologist,  
Department of Psychological 
Services and Research,  
Crichton Hall,  






Thank you for taking the time to read this information sheet 
If you wish to make a complaint about the study please contact  
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Patient Services Team 




























CONSENT FORM  
 
Study Title: Exploring cognitive biases in treatment decision making capacity 
of people who have experienced psychosis.  
 
Name of Researcher:  Amanda Larkin (Trainee Clinical Psychologist, NHS 
Dumfries and Galloway and University of Edinburgh)  
 
Participant ID: _________________________________________ 
 
Please initial in the box if you agree with the sentence:   
 
1.  I have read and understand the information sheet 
dated.................... (version............) for the above study. I have 




2. I understand that taking part is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.  
 
 
3. I know that some interviews will be recorded. I understand that 
these interviews will be recorded and written out word for word. I 
give permission for this to be done. I understand that these 




4. I agree to my GP being told that I am in the study. All the 
information I provide in the study will be anonymous and 
confidential. However, if I reveal information about future harm to 
myself, or others, that information will be passed on to the 
appropriate healthcare professional.  
 
 
5. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from the 
regulatory authorities and from the University of Edinburgh or from 
NHS Dumfries and Galloway where it is relevant to my taking part in 
the research. I give permission for those individuals to have access 
to my records.  
  
 








Name of Participant: ____________________________________ 
  
Date: _____________________________________________  
 












Original (x1) to be retained in site file  



















Appendix H Measures used in the study 
MacCAT-T Interview Schedule 
I am going to ask you some questions about a possible, hypothetical 
treatment. This discussion is just for the purpose of this interview and will not 
affect your actual treatment. First, I will describe to you what I believe is the 
problem. Then I’ll talk to you about the research treatment, and the possible 
risks and benefits. I will ask you to apply that information to yourself, and 
then I’ll ask you to make a decision about whether you would or would not 
want to take this medication if it were offered to you.  
Understanding disorder 
Disclosure 
1. Diagnosis  
2. Feature of disorder 
3. Feature of disorder  
4. Feature of disorder  
5. Course of disorder  
Now please explain in your own words what I’ve said about your condition.  
Re-disclose and re-enquire if necessary.  
 
Appreciation-disorder  
Now that is what I think is the problem in your case. If you have any reason 




1. Name of treatment: Medicine 1  
2. Feature of treatment: It can be taken as tablets or liquids twice a day 
3. Feature of treatment: You will start at a low dose and increase until we 
find the right dose for you.  
4. Feature of treatment: You ought to stay on the medication for at least 
2 years and see your doctor once a month  
Now please explain in your own words what I’ve said about this treatment  






1. Benefit: It will make your symptoms less troublesome  
2. Benefit: It will reduce the risk of relapse. With treatment 15% relapse. 
Without treatment 57% relapse 
3. Risk:  There is a low risk that you may experience problems such as 
abnormal movements of your mouth and tongue, which you cannot 
control. 
4. Risk:  There is a moderate risk that you may experience problems with 
weight gain 
Now please explain in your own words what I’ve said about benefits and risks 
of this treatment.  
Re-disclose and re-enquire if necessary.  
 
Appreciation-treatment 
You might or might not decide that this is the treatment you want – we’ll talk 
about it later. But do you think it’s possible that this treatment might be of 
some benefit to you?  
So you feel that it is / isn’t possible for this treatment to be of some help for 
your condition. Can you explain that to me? What makes it seem that the 
treatment would / wouldn’t be of possible benefit to you?  
 
Alternative treatments  
Disclosure 
1. Name of treatment: No treatment  
2. Feature of treatment: You do not have to take any tablets  
3. Feature of treatment: You will need to continue seeing a doctor or 
nurse or psychologist every month 
4. Feature of treatment:You ought to continue attending the service for at 
least 2 years 
Now please explain in your own words what I’ve said about this treatment  







1. Benefit: You do not have to take any tablets.  
2. Benefit: There is no risk of weight gain.  
3. Risk:  The likelihood is your symptoms will continue without treatment  
4. Risk: There is a high risk of relapse. Without treatment 57% of patients 
relapse within a year. 
 
Now please explain in your own words what I’ve said about benefits and risks 
of this treatment.  
Re-disclose and re-enquire if necessary.  
 
 
First choice and reasoning  
Now let’s review the choices that you have. First ....: second..... Which of 
these seems best for you? Which do you think you would be most likely to 
want?  
You think that (state patient’s choice) might be best. Tell me what it is that 
makes that seem better than the others.  
Discuss explanation to explore reasoning process.  
 
Generate consequences 
I told you about some of the possible benefits and risks or discomforts of 
(name the patient’s preferred treatment option). What are some ways that 
these might influence your everyday activities at home or at work?  
Now let’s consider (no-treatment option). What are some ways that the 




When we started this discussion you favoured (insert First Choice from 
earlier enquiry, or note that the patient seemed to be having difficulty 
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deciding). What do you think now that we have discussed everything? Which 
would you want to do?  
 

























PANSS Interview Guide  
I’ve got a list of questions here which we ask people who have had problems 
with their mental health. I ask everyone the same questions so some of them 
might not apply to you. I need to know mainly how you have been feeling 
over the past week.  
P.1 Delusions  
When you are by yourself what do you think about?  
What about imagining things that aren’t true?  
Some people have told me in the past that sometimes they feel that 
messages are directed to them from the TV or the radio, do you ever 
experience anything like that?  
Do you ever have thoughts that interfere with your thinking?  
How often do these things happen to you? Do these experiences affect your 
behaviour?  
Has this happened in the last week?  
 
P.2 Conceptual disorganisation – based on observation of behaviour during 
the interview.  
P.3 Hallucinatory behaviour 
Do you ever have strange experiences? Hear strange noises?  
Do you sometimes hear things that others don’t hear?  
Do you sometimes receive personal communications from the radio or 
television? From God?  
Do you sometimes hear voices inside your head? When? How often? Have 
you heard them today? How clear are they? How loud are they?  
Do the voices belong to someone you know? Who are they? How many are 
there? Do they speak to you, comment about you, or speak to each other?  
What do the voices say? Are they good or bad voices? Are you afraid of 
them?  
Do the voices tell you what to do? Give you direct orders?  
Do you obey the voices’ commands? Must you?  
Do ordinary things ever appear strange or distorted?  
Do you ever have visions or see things that others don’t? How often? How 
clear are these visions?  
Do the visions occur together with the voices or separately?  
Do you ever smell things that others don’t?  
Do you get strange sensations from within your body or feel something 
strange inside you?  
What do you make of these voices / visions / smells / etc.? Are they a 




P.4 Excitement  
Do you ever feel “hyped-up” or agitated? Tell me about it  
P.5 Grandiosity  
Do you think you are special in some way?  
Have you had any thoughts recently about having special powers, or being 
more important than other people?  
How do you compare to the average person? Better or worse?  
Do you have talents or abilities that most people don’t have?  
Do you have ESP? Can you read another person’s mind?  
Do you have special or unusual powers?  
Do you have a special mission in life? How did this come about?  
Are you a religious person? What is your relationship with God? Are you 
closer to God than others are? Are you one of God’s angels / children?  
 
P.6 Suspiciousness / Persecution – rated on thought content expressed in 
the interview and its influence on behaviour.  
P.7 Hostility 
Do you feel irritable?  
What sort of things irritate you?  
What do you do if you feel irritated?  
Do you ever argue with people?  
Do you ever get angry with people, or shout at people?  
 
N.1 Blunted affect – rated on observation during the interview  
N.2 Emotional Withdrawal 
How do you feel in your spirits?  
What do you do during the day? Do you have any hobbies?  
Do you go out at all? Who with?  
Do you have anyone to talk to about your problems? Do you think they 
understand?  
When you go out, do you usually only go if someone asks you to out with 
them?  
Do you ever call on family or friends and ask them if they would like to go 
out?  
Do your family and friends take an interest in your problems?  
Do people ever come and discuss their problems with you?  
 
N. 3 Poor Rapport – based on observations of behaviour during the interview 
N. 4 Passive / Apathetic Social Withdrawal  
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Is there anything that would stop you going out? How often does this 
happen?  
What sort of things interest you?  
How is your energy?  
Do you ever feel like you can’t be bothered to do anything? How often? What 
causes this?  
When you are with other people do you have a conversation with them? 
Why?  
How much time do you spend on your own? Why?  
 
N.5 Difficulty in Abstract Thinking  
Do you ever have difficulty explaining things?  
Do you ever have difficulties with your thinking?  
Can I test your memory a bit? Do some proverbs / similarities?  
Proverbs – have you heard this before? What does it mean to you?  
 Plain as the nose on your face  
 Carrying a chip on your shoulder 
 Two heads are better than one 
 Too many cooks spoil the broth  
 Don’t judge a book by its cover 
 One man’s food is another man’s poison  
 All that glitters is not gold 
 Don’t cross the bridge until you come to it  
 What’s good for the goose is good for the gander 
 The grass always looks greener on the other side 
 Don’t keep all your eggs in one basket  
 One swallow does not make a summer  
 A stitch in time saves nine  
 A rolling stone gathers no moss  
 The acorn never falls far from the tree  
 People who live in glass houses shouldn’t throw stones  
Similarities – how are _______ and _________alike?  
 Ball and orange  
 Apple and banana  
 Pencil and pen  
 Penny and pound  
 Table and chair  
 Tiger and elephant  
 Hat and shirt  
 Bus and train  
 Arm and leg 
 Rose and tulip  
 Uncle and cousin  
 The sun and the moon  
 Paintings and poems  
 Hilltop and valley  
 Air and water  




N. 6 Lack of Spontaneity and Flow of Conversation – based on observations 
during the interview  
 
N.7. Stereotyped Thinking – based on observations during the interview  
 
G.1. Somatic Concerns  
 
How have you been feeling?  
Is there any problem with your physical health?  
How is your head? How is your heart?  
Any trouble with any part of your body?  
Does your head or body ever feel strange?  
What is causing these problems?  
Have you seen the doctor about these problems? 
Do you have any medications for these problems? If not, why not?  
 
G.2. Anxiety  
 
Do you ever get anxious / worried about things?  
Have you ever had panic attacks?  
Have you been feeling nervous or tense?  
Would you please hold your hands out straight? (inspect for tremor)  
How anxious have you been feeling?  
Do you ever get into a state of panic?  
Have your worries or nervousness affected your sleep? Your appetite? Your 
ability to work?  
Does your heart race?  
Do you get butterflies in your stomach?  
Has it happened in the last week? How often?  
 
G.3. Guilt Feelings  
 
Do you get into moods where you blame yourself for things, feel guilty or 
down on yourself? About things in the past?  
Do you feel less worthwhile than the average person?  
Do you consider yourself a bad person in some ways?  
 
G.4. Tension  
 
Do you get tense? How often?  
What does that feel like? Do your muscles get tight?  




G.5 Mannerisms and Posturing -  based on observations of behaviour during 
the interview  
 
G.6. Depression  
 
How have you been feeling in your mood / spirits in the last few days?  
Have you felt bad in yourself, down in the dumps?  
What is your typical mood like?  
Are you mostly happy? Sad? Why?  
How unhappy have you been feeling?  
When do you feel the saddest? How long do these feelings last?  
Do you sometimes cry? How often?  
Has your mood affected your appetite? Your sleep? Your ability to work / 
concentrate?  
Have you had any thoughts of harming yourself or ending your life?  
How do you see your future?  
Do you get feelings of worthlessness or hopelessness?  
 






Do you attend a day hospital?  
How often do you go? Do you enjoy going?  
Do you ever do odd jobs around the house or for your family and friends?  
Do you take your medication regularly? If not, why not?  
Do you keep your appointments with your doctor or psychiatrist? How often 
do you miss them? Why?  
 
G.9. Unusual Thought Content – ratings based on behaviour and reported 
thought content during interview 
 
G.10. Disorientation  
 
I’d like to ask you some questions about your orientation?  
Do you sometimes forget the date / your address / names?  
Do you ever feel confused and not know where you are?  
What day of the week is it? What is today’s date? What season are we in?  
Where are we now located?  
What is the name of your doctor / psychiatrist?  




G.11. Poor Attention  
 
How long can you focus your attention? How long could you watch TV, read 
the newspaper, etc? Could you watch a film all the way through?  
Are you distracted by things easily?  
 
 
G.12. Lack of Judgement and Insight  
 
Are you in need of treatment?  
Do you have a psychiatric disorder? Have you had one in the past?  
What are the symptoms of your illness?  
Why are you taking medicine?  
What are your immediate plans for the future?  
What is your diagnosis?  
Do you agree with it?  
What have you been told about your illness? Do you agree with this? Why?  
 
G.13. Disturbance of Volition  
 
What is your explanation for the things happening to you?  
Do you feel like you’ve got drive to get up and do things of your own accord? 
If you got thirsty, would you go and make yourself a drink?  
Do you feel able to make decisions?  
Do your thoughts ever make it difficult for you to make decisions?  
Do you sometimes forget what you are doing?  
 
G.14. Poor Impulse Control  
 
Do you think that you are predictable?  
Do you do things on impulse sometimes?  
Do you ever break things if you lose your temper?  
 
G.15 Preoccupation – based on interpersonal behaviour observed during the 
interview  
 










Cognitive bias questionnaire for psychosis 
Cognitive Biases Questionnaire for Psychosis (Peters et al., 2013) 
 
Instructions:  In this questionnaire you will find a number of descriptions of 
everyday events. After each situation are different ways that people might react, 
labelled A, B, or C. Please imagine yourself in each situation as vividly as possible. 
 
Once you have imagined that the event is happening to you, please choose the option 
that best describes how you might think about the situation. If none of the options 
matches completely how you might react, choose the one which is the closest. If 
more than 1 option applies, choose the one which would run through your mind most 
often. When you have decided which option you are most likely to think, put a circle 
around the letter next to it. There are no right or wrong answers. Work through the 
questions fairly quickly, making sure you pick the option that is nearest to what your 
immediate reaction might be.  
 
1. Imagine you receive a letter and you 
notice it is not sealed.  
 
I am most likely to think: (please circle 
A, B, or C) 
 
A. Somebody has deliberately opened 
this letter already.  
B. I wonder if this may have been 
opened again after it was written.  
C. I don’t think anything of it.  
 
2. Imagine that you are walking down 
the street when you hear your name 
being called, but when you look around 
you don’t see  
anybody. 
 
 I am most likely to think: (please circle 
A, B, or C) 
 
A. Something strange is going on.  
B. There is something really 
dangerous about this.  
C. I must be imagining things.  
3. Imagine your food tastes different 
from usual.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. Someone may have done 
something to my food on purpose.  
B. This food must have been 
prepared with a different 
ingredient today.  
C. Someone has deliberately spiked 
my food.  
 
4.  Imagine that on your way to work 
you notice that all the traffic lights turn 
red as you approach them.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. It’s going to take me longer to get 
in this morning.  
B. That’s all I need, I’m going to be 
really late now.  
C. My day is going to be ruined.  
 
5. Imagine you are standing at a bus stop 
when the bus you have been waiting for 
drives past half empty without stopping.  
A. People are always so nasty.  





I am most likely to think: (please circle 






C. The driver must be in a bad mood 
today.  
6. Imagine you have a really bad pain in 
your head.  
 
I am most likely to think: (please circle 




A. There must be something wrong 
with me.  
B. There’s lots of different reasons 
why I might have this pain.  
C. I must have something really 
serious, like a brain tumour.  
 
7. Imagine that while on the bus, you 
notice a stranger staring at you.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. The way this person is staring at 
me is a bit worrying.  
B. This person must mean me harm 
to be staring at me that way.  
C. This person is being really rude to 
be staring at me in that way.  
 
8. Imagine you are sitting at home and 
you suddenly feel very odd.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. I wonder why I feel odd, could 
something sinister be going on 
somewhere. 
B. This feeling is proof there is 
something bad happening 
somewhere to someone I know.  
C. I must be overtired or something.  
 
9. Imagine you applied for a job and did 
not get it.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. Perhaps I can get some feedback 
about why I did not get the job.  
B. I wonder if I did not do very well 
at the interview.  
C. I’ll never be able to get a job. 
 
10. Imagine that you are on a train when 
you suddenly have a strong feeling you 
have been there before.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. This is some kind of premonition 
that something awful has 
happened or will happen.  
B. I wonder if this is some kind of 
premonition.  
C. This is a weird, but common 
experience.  
11. Imagine you get turned down to go 
out by someone you like or a friend.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. I quite often get rejected in this 
situation.  
B. You win some, you lose some.  
C. I always get rejected for anything 
I try.  
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12. Imagine that one day you enter a 
shop and you hear people laughing.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. They must be laughing at me.  
B. I wonder if they are laughing at 
me.  
C. The laughing is probably nothing 
to do with me.  
13. Imagine there are police cars outside 
your house. You suddenly realise you 
feel uncomfortable.  
 
I am most likely to think: (please circle 
A, B, or C)   
A. Funny how just seeing the police 
has this unsettling effect on 
people.  
B. I wonder why I feel so 
uncomfortable, could the cars be 
something to do with me.  
C. I must have done something 
wrong to feel so uncomfortable, 
they’ve come to get me. 
 
14. Imagine you are watching television, 
and suddenly the screen goes blank. 
 
I am most likely to think: (please circle 
A, B, or C)  
A. Weird things are always 
happening.  
B. This sort of thing seems to happen 
quite a lot.  
C. There must be something wrong 
with the TV today.  
15. Imagine two people in a queue at the 
supermarket both look your way at the 
same time and then immediately start to 
talk to each other.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. This is not the first time this has 
happened.  
B. This sort of thing can happen in 
queues.  
C. This always happens wherever I 
go.  
 
16. Imagine you are waiting in a cafe for 
an acquaintance to arrive, and you 
suddenly feel a strange shivery feeling 
inside.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. Feeling shivery is a bad omen, I 
don’t think I should meet this 
person.  
B. I must be nervous about meeting 
this person.  
C. I wonder if feeling shivery means 
something bad might happen.  
17. Imagine you think you see a 
shadowy figure moving across the wall 
of an empty room.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. I wonder what that was.  
B. My eyes must be playing tricks on 
me.  
C. There must have been someone or 
something there.  
18. Imagine that the phone rings. When 
you answer, the other party hangs up.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. I wonder if there’s something 
suspicious about this.  
B. Somebody is definitely checking 
up on me.  
C. Someone’s probably got the 
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wrong number.  
 
19. Imagine you are watching the news 
on TV about a recent disaster, and you 
find yourself feeling guilty.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. If I feel guilty, I must be 
responsible in some way.  
B. It’s normal to feel guilty when a 
disaster has happened to someone 
else.  
C. I wonder why I feel guilty, maybe 
I’m unwittingly responsible in 
some way.  
20. Imagine you are listening to the 
radio and suddenly there is crackling 
interference.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. Someone has deliberately 
tampered with my radio so that it 
is no longer tuned properly.  
B. I wonder if someone has been 
fiddling with my radio.  
C. There is some sort of interference 
on the radio waves.  
 
21. Imagine that you are sitting on a 
train, and you think you can hear two 
people behind you talking about you. 
When you look round, they are reading 
their papers and not talking to each 
other.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. They were definitely talking about 
me, they’re just pretending to read 
their paper.  
B. I’m sure I heard them talking 
about me, maybe I was wrong.  
C. I should find out if anyone else 
ever has this kind of experience 
before deciding what really 
happened.  
 
22. Imagine you are at home; everything 
is quiet when you hear a sudden fast 
banging on the walls.  
 
I am most likely to think: (please circle 





A. The neighbours are doing this 
deliberately to upset me.  
B. The neighbours could be doing 
some kind of home improvement. 
C. The neighbours must be trying to 
tell me something. 
 
23. Imagine you are reading a 
newspaper or magazine, and you read an 
article that has some special relevance to 
you.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
 
A. This article seems to have been 
written with people like me in 
mind.  
B. I wonder if someone may have 
written this article for me. 
C. Someone has definitely written 
this article for me specifically.  
24. Imagine you notice that a person you 
don’t know is looking at you. You 
suddenly find yourself feeling unsettled.  
A. Feeling this unsettled means this 
person intends to do me harm. 




I am most likely to think: (please circle 
A, B, or C)  
 
could this mean this person is 
thinking bad things about me.  
C. Being looked at can make people 
feel unsettled, I don’t worry about 
it.  
 
25. Imagine that one evening you are 
sitting at home alone when a door 
suddenly slams by itself in another 
room.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. Someone or something must have 
gotten into the house.  
B. I wonder if somebody or 
something’s there.  
C. It’s probably a draught.  
26. Imagine someone you know calls 
you just as you were thinking about 
them. As you pick up the phone, you 
suddenly realise you are feeling upset.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. It’s odd that I should feel upset, 
but I don’t read too much into it.  
B. I wonder why I feel upset, could 
there be something peculiar about 
this call.  
C. Feeling upset means something, it 
must be bad news.  
 
27. Imagine you are walking down the 
road when you suddenly notice a careers 
poster which seems to stand out from 
your surroundings.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. I wonder why my eyes seem 
drawn to that poster.  
B. Maybe I’m noticing it because my 
career isn’t such a success.  
C. It’s a sign that my life is such a 
failure.  
 
28. Imagine you are on a bus; the bus 
driver keeps stopping abruptly, so that 
you stumble each time.  
 
I am most likely to think: (please circle 
A, B, or C)  
 
A. I wonder if he’s doing it on 
purpose to wind people up.  
B. This bus driver can’t drive 
properly.  
C. He’s doing it on purpose to 
humiliate me.  
29. Imagine you hear that a friend is 
having a party and you have not been 
invited.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. I wonder if they don’t like me as 
much as I thought they did.  
B. Perhaps I can try to find out a bit 
more about the situation before 
making any assumptions.  
C. They obviously don’t like me.  
 
30. Imagine you are dozing on the sofa 
in front of the TV and you suddenly 
wake up startled.  
 
I am most likely to think: (please circle 
A, B, or C)  
A. I tend to always wake up startled 
when I’m dozing.  
B. The TV must have woken me. 































Beck Cognitive Insight Scale  
Below is a list of sentences about how people think and feel. Please read each 
sentence in the list carefully. Indicate how much you agree with each statement by 













1. At times, I have misunderstood 
people’s attitudes towards me.  
 
0 1 2 3 
2. My interpretations of my experiences 
are definitely right.  
 
0 1 2 3 
3. Other people can understand the 
cause of my unusual experiences 
better than I can. 
 
0 1 2 3 
4. I have jumped to conclusions too 
fast.  
 
0 1 2 3 
5. Some of my experiences that have 
seemed very real may have been due 
to my imagination.  
 
0 1 2 3 
6. Some of the ideas I was certain were 
true turned out to be false.  
 
0 1 2 3 
7. If something feels right, it means that 
it is.  
 
0 1 2 3 
8. Even though I feel strongly that I am 
right, I could be wrong.  
 
0  1 2 3 
9. I know better than anyone else what 
my problems are.  
 
0 1 2 3 
10. When people disagree with me, they 
are generally wrong.  
 
0 1 2 3 
11. I cannot trust other people’s opinions 
about my experience.  
 
0 1 2 3 
12. If somebody points out that my 
beliefs are wrong, I am willing to 
consider it.  
 
0 1 2 3 
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13. I can trust my own judgement at all 
times.  
 
0 1 2 3 
14. There is often more than one 
possible explanation for why people 
act the way they do.  
 
0 1 2 3 
15. My unusual experiences may be due 
to my being extremely upset or 
stressed. 











































Recovery Assessment Scale  
 
I am going to read a list of statements which people sometimes use to describe 
themselves and their lives. Please listen carefully to each one and indicate the 
response that best described the extent to which you agree or disagree with the 
statement. For each of these statements, please indicate whether you strongly 









1. I have a desire to succeed 
 
1 2 3 4 5 
2. I have my own plan for 
how to stay or become 
well.  
 
1 2 3 4 5 
3. I have goals in life that I 
want to reach.  
 
1 2 3 4 5 
4. I believe I can meet my 
current personal goals.  
 
1 2 3 4 5 
5. I have a purpose in life.  
 
1 2 3 4 5 
6. Even when I don’t care 
about myself, other people 
do.  
 
1 2 3 4 5 
7. I understand how to 
control the symptoms of 
my mental illness.  
 
1 2 3 4 5 
8. I can handle it if I get sick 
again.  
 
1 2 3 4 5 
9. I can identify what triggers 
the symptoms of my 
mental illness. 
  
1 2 3 4 5 
10. I can help myself become 
better.  
 
1 2 3 4 5 
11. Fear doesn’t stop me from 
living the way I want to.  
 
1 2 3 4 5 
12. I know that there are 
mental health services that 
do help me.  
 









13. There are things that I can 
do that help me deal with 
unwanted symptoms.  
 
1 2 3 4 5 
14. I can handle what happens 
in my life.  
 
1 2 3 4 5 
15. I like myself.  
 
1 2 3 4 5 
16. If people really knew me, 
they would like me.  
 
1 2 3 4 5 
17. I am a better person than 
before my experience with 
mental illness.  
 
1 2 3 4 5 
18. Although my symptoms 
may get worse, I know I 
can handle it.  
 
1 2 3 4 5 
19. If I keep trying, I will 
continue to get better.  
 
1 2 3 4 5 
20. I have an idea of who I 
want to become.  
 
1 2 3 4 5 
21. Things happen for a 
reason.  
 
1 2 3 4 5 
22. Something good will 
happen eventually.  
 
1 2 3 4 5 
23. I am the person most 
responsible for my own 
improvement.  
 
1 2 3 4 5 
24. I’m hopeful about my 
future.  
 
1 2 3 4 5 
25. I continue to have new 
interests.  
 
1 2 3 4 5 
26. It is important to have fun.  
 
1 2 3 4 5 
27. Coping with my mental 
illness is no longer the 
main focus of my life.  
 









28. My symptoms interfere 
less and less with my life.  
 
1 2 3 4 5 
29. My symptoms seem to be 
a problem for shorter 
periods each time they 
occur.  
 
1 2 3 4 5 
30. I know when to ask for 
help.  
 
1 2 3 4 5 
31. I am willing to ask for 
help.  
 
1 2 3 4 5 
32. I ask for help, when I need 
it.  
 
1 2 3 4 5 
33. Being able to work is 
important to me.  
 
1 2 3 4 5 
34. I know what helps me get 
better.  
 
1 2 3 4 5 
35. I can learn from my 
mistakes.  
 
1 2 3 4 5 
36. I can handle stress.  
 
1 2 3 4 5 
37. I have people I can count 
on.  
 
1 2 3 4 5 
38. I can identify the early 
warning signs of becoming 
sick.  
 
1 2 3 4 5 
39. Even when I don’t believe 
in myself, other people do.  
 
1 2 3 4 5 
40. It is important to have a 
variety of friends.  
 
1 2 3 4 5 
41. It is important to have 
healthy habits.  
 







Appendix I Factor structure of the PANSS used in study  
 
Five factor model (Rodriguez-Jiminez et 
al., 2013)  
Pentagonal model (White et al., 1997) 
Positive Factor  Positive Factor 
P1 Delusions P1 Delusions 
G9 Unusual thought content G9 Unusual thought content 
P3 Hallucinatory Behaviour P5 Grandiosity  
P5 Grandiosity P3 Hallucinatory behaviour  
Negative Factor G1 Somatic Concern  
N3 Poor rapport Negative Factor 
N1 Blunted affect  N6 Lack of spontaneity  
N2 Emotional withdrawal  N1 Blunted affect  
N6 Lack of spontaneity  N2 Emotional withdrawal 
N4 Passive / apathetic social withdrawal  N3 Poor rapport 
G7 Motor retardation N4 Passive / apathetic social 
withdrawal 
Disorganised / Concrete (Cognition) 
Factor  
G7 Motor retardation 
N5 Difficulty in abstract thinking  G5 Mannerisms and posturing  
P2 Conceptual disorganisation G8 Uncooperativeness 
G11 Poor attention  G13 Disturbance of volition 
Excited Factor  G14 Poor impulse control  
P4 Excitement Disorganised / autistic preoccupation 
G14 Poor impulse control  G11 Poor attention 
P7 Hostility  G15 Preoccupation 
G8 Uncooperativeness N5 Difficulty in abstract thinking  
Depressed Factor  N7 Stereotyped thinking 
G3 Guilt feelings  G13 Disturbance of volition 
G6 Depression  P3 Hallucinatory behaviour 
G2 Anxiety  Excited / activation  
 P7 Hostility  
 G14 Poor impulse control  
 P4 Excitement 
 G8 Uncooperativeness 
 N3 Poor rapport 
 G4 Tension 
 Dysphoric mood / Emotional distress 
 G2 Anxiety 
 G4 Tension 
 G3 Guilt feelings 
 G6 Depression 
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